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Abstract
Every day billions of cells in our bodies undergo apoptosis and are cleared through
efferocytosis – a phagocytosis-like process in which phagocytes engulf and degrade
apoptotic cells. Proper processing of efferosomes prevents inflammation and immunogenic
presentation of antigens. In this thesis I determined that the early stages of efferosome
maturation parallel that of the pro-immunogenic phagocytosis of pathogens. Mass
spectrometry analysis of later maturation stages identified unique regulatory proteins on
efferosomes and phagosomes. Keys among these were Rab17 and Rab45 on efferosomes
versus Rab6b and PI-4-Kinase on phagosomes. The later would allow for antigen
presentation from phagosomes, while the former would direct efferosome-derived antigens
away from this presentation pathway. Moreover, positive regulators of MAP-kinase signaling
were enriched on phagosomes, while negative regulators were enriched on efferosomes,
perhaps indicating the mechanism through which efferocytosis inhibits inflammation. These
regulators may account for the differences in inflammation and immunogenicity observed
after efferocytosis versus phagocytosis.
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Chapter 1 - Introduction
1.1 Apoptosis
Apoptosis, the programmed cell death of old, damaged or unneeded cells, is triggered by
multiple factors including exogenous stimuli such as pathogen infection and engagement
of pro-apoptotic receptors, and endogenous stimuli such as aging, and damage from
physical or chemical stresses1. Apoptotic cells must be cleared in order to maintain an
organism’s normal physiological functions and tissue homeostasis. Upon recognition by
phagocytic cells, apoptotic cells are cleared promptly and efficiently. For example,
neutrophils in the peripheral circulation system have a high incidence of apoptosis due to
their short half-life, but the number of apoptotic neutrophils remains at a low basal level
due to their efferocytic removal by macrophages in the bone marrow2. In instances where
apoptotic cells are not efficiently removed, chronic inflammation and autoimmunity can
occur. Apoptotic cells display many distinct hallmarks that are excluded from healthy
cells such as membrane blebs on their surfaces as a result of increased intracellular
hydrostatic pressure from actomyosin contractility of the cortical cytoskeleton3. This
blebbing process is induced as a part of the apoptotic signaling pathway, which is driven
by cysteine-dependent aspartate-driven proteases termed caspases4. Upon initiation of
apoptosis by internal stress and damage (intrinsic pathway), pro-apoptotic factors induce
the release of cytochrome C from mitochondria, which then complexes with the cytosolic
protein apoptosis activating factor-1 (Apaf-1). Caspase 9 is recruited to this complex,
forming a structure termed the “apoptosome”, which then activates caspase 3, an
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executioner caspase that begins the disassembly of the cell5. Blebbing of the apoptotic
cell is initiated by activated caspase 3, which cleaves the C-terminus of Rho-associated
coiled-coil-containing protein kinase 1 (ROCK1), forming a constitutively active enzyme
which then phosphorylates myosin light chain kinase. The resultant activation of myosin
II leads to cortical actin contraction and increased intracellular hydrostatic pressure, thus
producing membrane blebs. Actin is cleared from the growing blebs, and later replaced in
mature blebs through late stage actin repolymerization3. Caspase 3 also activates other
cell degrading proteins such as Caspase-activated DNAse (CAD) which fragments the
nuclear DNA, which is then dispersed to the forming blebs6. Other cellular
compartments (e.g. the Golgi apparatus, endoplasmic reticulum, and mitochondria) are
broken down and packaged in a similar fashion as nuclear DNA fragments, while
activation of enzymes such as lipid scramblases and phospholipases lead to the exposure
of “find-me” and “eat-me” signals which enable the recognition of apoptotic cells by
phagocytes (discussed in Section 1.3). Once released, these blebs are termed apoptotic
bodies, which are ultimately identified and removed through efferocytosis7.
Throughout this process the apoptotic cell membrane remains intact, thus preventing the
release of intracellular proteins, while the small size of the released blebs plus the
exposure of “find-me” and “eat-me signals” enhances uptake byphagocytes3, 8. However,
if apoptotic cells are not cleared, the membrane integrity of apoptotic bodies becomes
unstable, culminating with the release of intracellular materials into the extracellular
milieu through a process called secondary necrosis. This can lead to negative
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immunological consequences including chronic inflammation and autoimmune diseases1,
9, 10, 11

.

1.2 Macrophage Subtypes
Macrophages, a type of professional phagocyte, have classically been regarded as
leukocytes whose main function is the phagocytosis (engulfment and clearance) of
pathogens. They also have minor roles in antigen presentation and regulation of the
innate and adaptive immune systems through cytokine production. Recent studies
revealed that macrophages have additional important roles in homeostasis and wound
healing, in addition to their roles during infection. This multi-functional activity of
macrophages is mediated in part by their polarization into distinct subsets, each with
unique functions: 1) M1 macrophages which engage in the pro-inflammatory/prophagocytic activities classically assigned to macrophages, 2) M2 macrophages which
drive wound healing and tissue remodeling responses, and 3) M0 (unpolarized)
macrophages which patrol tissues and may engage in homeostatic processes such as
efferocytosis within uninfected/undamaged tissues12, 13.
In vitro, each subtype can be derived from monocytes isolated from peripheral blood,
which are then differentiated by the addition of either granulocyte-macrophage colony
stimulating factor (GM-CSF) or macrophage colony stimulating factor (M-CSF),
followed by administration of additional cytokines14. GM-CSF plus the addition of proinflammatory compounds such as IFN-γ and LPS result in the differentiation of M1
macrophages, whereas M-CSF plus regulatory cytokines such as IL-4 or IL-13 generate
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M2 macrophages. M0 macrophages are produced by culturing with M-CSF alone, thus
avoiding the polarizing effects of inflammatory or regulatory cytokines12.
Jaguin et al. characterized in the patterns of cytokine production in each macrophage
type12. M1 macrophages, which both produce and react to pro-inflammatory cytokines
such as IFN-γ and TNF-α, exhibit enhanced phagocytosis of pathogens compared to other
macrophage subtypes. M2 cells function through the production of anti-inflammatory
cytokines such as TGF-β and enhance following internalization of apoptotic cells or entry
into wound sites15. Unpolarized M0 macrophages appear to resemble resident
macrophages in healthy tissues, and display a phenotype distinct from M1 cells, but with
some similarities to M2 cells16. Importantly, M0 cells can differentiate into either M1 or
M2 cells, although it is not clear if M1 or M2 cells are capable of further differentiation14,
17

. Functional differences between M1 and M2 macrophages have been widely studied,

especially in their production of reactive oxygen species production after phagocytosis;
M1 cells produce high NADPH oxidase activity following phagocytosis, whereas M2like macrophages produce minimal NADPH oxidase activity18. This may result in
differences in antigen presentation and degradation of phagocytic/efferocytic cargos19.
Some of these functional differences are explored later in this thesis.

1.3 Overview of Efferocytosis
Efferocytosis, the process through which phagocytes recognize and ingest (phagocytose)
apoptotic cells, maintains tissue homeostasis by regulating cell numbers and remodels
tissues in an anti-inflammatory fashion. The clearance of apoptotic cells is achieved
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through the stepwise removal of apoptotic corpses by: 1) Recruitment of phagocytes to
“find-me” signals secreted by apoptotic cells, 2) Display of “eat-me” signals on apoptotic
cells which are then bound by efferocytic receptors on phagocytes, 3) Internalization of
apoptotic cells by receptor mediated signaling pathways, and 4) Digestion of apoptotic
cells by an efferosome maturation process within the phagocyte11. Although efferocytosis
is considered as an anti-inflammatory process, the mechanism by which apoptotic cells
are degraded in a fashion which prevents inflammation and maintains immunological
silence is not understood.
Phagocytes migrate to sites of apoptosis by following “find-me” signals, soluble
chemotactic molecules released from apoptotic cells such as lysophosphatidylcholine
(LPC)20. Receptors on phagocytes then bind to “eat-me” signals displayed by apoptotic
corpses. Among the many “eat-me” signals, phosphatidylserine (PtdSer) is a wellcharacterized and widely utilized apoptotic signal21. Apoptotic cells also express
additional “eat-me” signals such as calreticulin and oxidized lipids on their surfaces21, 22.
These are recognized by multiple surface receptors on phagocytes, which bind to
apoptotic cells either directly or indirectly through soluble bridging molecules termed
opsonins. Upon internalization, apoptotic corpses are retained in a membrane-sealed
vacuolar structure called the efferosome, where it is processed and degraded23. The
resulting self-antigens are either presented without activating co-stimulatory molecules or
presentation is avoided completely after the efferosome maturation process is complete11,
24

. These processes which comprise efferocytosis are explored in greater detail below.
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Find-me signals
Prior to recognition and internalization of apoptotic cells, phagocytes must be recruited to
the location in which cells are undergoing apoptosis. This occurs through the release of
“find-me” signals which act as chemoattractants that direct phagocytes to sites of
apoptosis. The range of these “find-me” signals depends on their concentration and halflife, which may vary between tissues21. “Find-me” signals identified to-date include LPC,
fractalkine (CXCL3), adenosine triphosphate (ATP) and uracil triphosphate (UTP)
nucleotides, and sphingosine-1-phosphate (S1P)21.
Peter et al. showed that calcium-independent phospholipase-A2, activated by caspase 3,
produces LPC which is then released into the extracellular matrix20. This soluble LPC
signals through the receptor G2A, G-protein-coupled receptor found on macrophages,
thus allowing macrophages to migrate towards the apoptotic cell. However, these
observations are controversial as the study of Lauber et al. demonstrated that
significantly higher concentrations of LPC were required for chemotaxis than were
normally released by apoptotic cells25. In fact, this study showed that the membrane
damage caused by production of the quantity of LPC required for chemotaxis would lead
to lysis of the apoptotic cell. The role of LPC as a find-me signal is controversial for an
additional two reasons; namely that it is relatively insoluble and therefore is not expected
to diffuse and form gradients in vivo, and because it is unclear if G2A is truly a receptor
for LPC26.
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Fractalkine is a membrane tethered cytokine with dual functions as an adhesion molecule
and chemokine27. Apoptotic neurons and B cells rapidly produce and shed fractalkine,
which then attracts macrophages and microglia via the fractalkine receptor CX3CR27.
Miksa et al. showed that fractalkine also contributed to recognition and engulfment of
apoptotic cells by upregulating milk fat globule EGF factor 8 (MFG-E8) expression, an
opsonin which enhances efferocytosis via the MerTK efferocytic receptor27. However,
fractalkine’s role in attracting phagocytes to sites of apoptosis remains elusive. Although
fractalkine enhanced MFG-E8 production in microglia, efferocytosis by microglia was
not observed27. Moreover, the role of fractalkine in attracting macrophages at sites where
it is produced – e.g. Kupffer cells in the liver and alveolar macrophages in the lungs - has
not been studied, meaning further research is required to elucidate fractalkine’s role as a
“find-me” signal. Finally, fractalkine’s role as a find-me signal appears to be limited to
immune cells undergoing apoptosis, rather than a universal find-me signal produced by
all apoptotic cells.
Apoptotic cells release small amounts of ATP and UTP that induce chemotaxis of
phagocytes to apoptotic cells26. Again, the role of these nucleoside triphosphate remains
controversial as ATP and UTP can also function as danger-associated molecular patterns
(DAMPs) which are usually associated with necrosis and initiation of pro-inflammatory
responses11. Once ATP and UTP are present in the extracellular space, phagocytes
respond via the purinergic receptor P2Y2. Again, the role of these “find-me” signals
remains unclear, as these nucleotides are short-lived in the extracellular milieu as they are
rapidly degraded by extracellular nucleotidases26, 28. Thus ATP and UTP’s function as
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find-me signals would be limited to attracting neighbouring phagocytes rather than cells
residing in the circulation or at more distal sites.
The best characterized “find-me” signal is sphingosine-1-phosphate (S1P). Unlike the
previously mentioned find-me signals, S1P appears to be produced by all apoptotic cells,
is highly soluble, and has a sufficiently long half-life to recruit cells over long distances29.
S1P is derived from sphingomyelin, a lipid found in the plasma membrane. Once cells
undergo apoptosis, sphingomyelinase processes sphingomyelin to sphingosine, followed
by caspase activated sphingosine kinases phosphorylating sphingosine to form soluble
sphingosine-1-phosphate (S1P). S1P induces chemotaxis of phagocytes through the S1P
receptor, with chemotaxis occurring at physiologically relevant concentrations of S1P 11,
29, 30

. Moreover, S1P is anti-inflammatory31, as would be expected of a “find-me” signal

released during apoptosis.
How these various “find-me” signals interact to optimize in recruiting phagocytes is not
completely elucidated. For example it is not yet clear whether they are synergistic or nonsynergistic in attracting phagocytes, and how they interact with proposed inhibitory
“don’t find-me” signals32.
Eat-me signals
Once professional phagocytes are recruited to a site where cells are undergoing apoptosis,
phagocytes must distinguish healthy cells from apoptotic cells prior to engulfment.
Apoptotic cells are recognized by several “eat-me” signals present on the extrafacial
surface of their plasma membrane. The plasma membrane of apoptotic cells displays
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numerous changes in glycosylation patterns of proteins and lipids, changes in lipid
composition and changes in surface charge, all while maintaining an intact membrane11.
These changes to the plasma membrane all act as “eat-me” signals which are recognized
by receptors on phagocytes11, 26. Of these “eat-me” signals, phosphatidylserine (PtdSer),
is the best characterized. PtdSer is normally restricted to the inner leaflet of the plasma
membrane, but is flipped to the outer leaflet plasma membrane during apoptosis. This
PtdSer flipping to the outer leaflet is dependent of caspase activity during apoptosis, in
which the transmembrane protein 16F (TMEM16F) acts as a scramblase that randomly
sorts phospholipids, including PtdSer and phosphotidylethanolamine (PtdEtn), in a
calcium-dependent manner across the leaflets of the plasma membrane33. The signalling
that induces this process is still poorly understood, but it is established that the formation
of a cytosolic Ca2+ gradient is required to activate TMEM16F33. The same study showed
that knockout of Tmem16f, using small hairpin RNA, downregulates the scrambling of
PtdSer and PtdEtn during apoptosis. In addition, Scott syndrome patients have defective
TMEM16F due to a splice mutation of TMEM16F and their platelets and blood cells
cannot expose PtdSer and PtdEtn on the outer leaflet of the plasma membrane 33.
Additional “eat-me” signals include calreticulin, intracellular adhesion molecule 3
(ICAM3), and binding of serum proteins such thrombospondin and complement C1q to
the cell surface11. Calreticulin is a protein normally located in the endoplasmic reticulum
(ER), sarcoplasmic reticulum (SR) and nucleus. However, once cells undergo apoptosis,
calreticulin is transported via the secretory pathway to the plasma membrane where it
becomes accessible to its receptor, low density lipoprotein receptor-related protein
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(LRP)/CD91, which is expressed on macrophages35. Apoptotic cells also expose other
molecules such as oxidized lipids and unusually glycosylated lipids and proteins, which
are engaged by scavenger receptors such as CD3622. Despite the large number of
identified “eat-me” signals, only PtdSer has been studied in detail, and is the most
commonly used apoptotic cell surface marker due to its exposure on apoptotic cells in
abundant quantities, as well as the identification of several well characterized PtdSer
receptors on phagocytes11. It is unlikely that PtdSer on its own is sufficient for
efferocytosis, as some healthy cells also display PtdSer on the outer leaflet of their
plasma membrane without being targeted by phagocytes. For example, platelets expose
PtdSer as part of the clotting process, while maturing B and T cells expose PtdSer in
lymph nodes for an unknown purpose10, 36, 37, 38. A part of the reason these cells may not
be removed is the co-expression of CD31 and an integrin associated protein, CD47,
which act as “don’t eat-me” signals. The function of CD31 is not well understood, but
CD47 is known to bind to a specific receptor, signaling regulatory protein α (SIRPα),
which contains an immunoreceptor tyrosine-based inhibition motif (ITIM) that inhibits
phagocytosis. Thus CD31 and CD47 on healthy cells appear to prevent efferocytosis
through inhibiting phagocytic signaling10, 11, 35.
Efferocytic receptors mediate internalization of apoptotic cells
Once professional phagocytes recognize “eat-me” signals the phagocytes quickly
internalize the apoptotic cell. This is driven by two main groups of efferocytic receptors–
those that directly bind to “eat-me” signals (e.g. TIM-4, Stabilin2, CD36 and BAI1) and
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those which indirectly bind to “eat-me” signals (e.g. Tyro-3-Axl-MER and αvβ5) via
opsonins (e.g. Gas6, MFG-E8)10, 11.
TIM-4 (Table 1) has recently been highlighted as an important apoptotic cell receptor,
and is able to support the binding and internalization of apoptotic cells independent of
opsonins. A recent study showed that internalization of PtdSer-coated glass beads that
mimic apoptotic cells was dependent on TIM-4, with TIM-4 knockout mouse bone
marrow derived macrophages (BMDM) being unable to internalize these beads. However,
this paper likely over-simplified what is occurring, as other studies have shown that
PtdSer on its own does not act as an “eat-me” signal, with additional signals such as the
oxidation of the PtdSer being required for efferocytosis to occur22, 39, 40. Internalization of
PtdSer-coated beads required crosslinking of TIM-4 and the β1 integrin, which led to
downstream activation of Src family and focal adhesion kinases (FAK), followed by actin
polymerization driven by activation of Rac1 and Rac234. Additional PtdSer receptors may
also be involved in this internalization process. For example, brain-specific angiogenesis
inhibitor 1(BAI1, Table 1), a G-protein coupled receptor, binds to PtdSer and cardiopilin
via a binding site composed of five thrombospondin type 1 repeats (TSRs). Upon binding
of PtdSer on apoptotic cells, BAI1 induces activation of the Rac1 guanine exchange
factor (GEF) complex ELMO/DOCK180 to mediate Rac-activation, leading to
internalization of the apoptotic cell. BAI1 knockout in primary astrocytes and J774
macrophages decreased internalization of apoptotic thymocytes and carboxylate beads
that mimic apoptotic cells, supporting the concept that efficient efferocytosis requires the
concordant activation of several receptors30, 41.
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Table 1: Multiple efferocytic receptors are required to enhance efferocytosis
Professional phagocytes express multiple efferocytic receptors that optimize capture and
engulfment of apoptotic cells. Receptors either bind directly to PtdSer or indirectly via
opsonins that connect receptors with “eat-me” signals and enhance internalization of
apoptotic cells.
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Receptors	
  

Opsonins	
  

Eat-‐me	
  signals	
  

References	
  

TIM4	
  

−	
  

PtdSer	
  

34	
  

BAI1	
  

−	
  

PtdSer	
  

41	
  

CD36	
  

−	
  

oxLipids	
  (ex.	
  oxPtdSer)	
  

42	
  

Stabilin-‐2	
  

−	
  

PtdSer	
  

43	
  

CD91	
  

Calreticulin,	
  C1q,	
  MBL	
  

Modified	
  

44	
  

Glycoproteins/Glycolipids	
  
MER	
  

GAS6,	
  Protein	
  S,	
  Tubby	
  

PtdSer	
  

10,	
  11,	
  45,	
  46	
  

PtdSer	
  

10,	
  11	
  

and	
  tubby-‐like	
  protein	
  1	
  
αvβ3/5	
  

MFG-‐E8	
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CD36 (Table 1) is a class B scavenger receptor that binds to various ligands including
oxidized LDL (oxLDL) and oxidized lipids. In atherosclerosis this receptor drives the
accumulation of cholesterol inside macrophages, forming foam cells22. In addition to
removing oxLDL, CD36 also acts as an efferocytic receptor by binding to oxidized lipids
including oxidized PtdSer22. Early studies revealed that the PtdSer binding site in CD36
is separate from the LDL binding site22, 42. Critically, a recent study shows CD36 to be
capable of engulfing apoptotic cells in primary mouse peritoneal macrophages (MPM),
with binding occurring between CD36 and oxidized PtdSer rather than normal PtdSer22.
Interestingly, CD36 knockout primary MPM show decreased internalization of oxidized
PtdSer-coated vesicles versus increased non-oxidized PtdSer-coated vesicles, hinting that
CD36 may act to both drive efferocytosis and inhibit the removal of cells displaying
PtdSer in a non-apoptotic (e.g. non-oxidized) context22.
Stabilin-2 (Table 1) contributes to internalization of apoptotic cells through binding
PtdSer via extracellular epidermal growth factor like domain repeats (EGFrps). Stabilin-2
induces downstream signaling through the intracellular adaptor protein GULP, but the
resulting signaling process remains elusive. Importantly, the integrin binding domain
(FAS1) of Stabilin-2 directly interacts with integrin αvβ5 and activates
ELMO/DOCK180/Rac complex to induce actin polymerization followed by
internalization of apoptotic cells43. This may allow this receptor to engage the classical
integrin-mediated phagocytosis internalization pathway10.
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Previous studies by Gardai et al. introduced CD91 (known as a scavenger receptor and
LDL-receptor-related protein, Table 1) on macrophages, which binds to calreticulin on
apoptotic cells35. Apoptotic cells translocate calreticulin, an ER chaperone, to the plasma
membrane. Engagement of calreticulin by CD91 initiates efferocytosis6. In addition to
binding calreticulin, CD91 mediates efferocytosis in response to a number of other “eatme” signals, including C1q deposited on the apoptotic cell surface, the binding of
mannose binding lectin (MBL) to glycoproteins and glycolipids modified by apoptotic
processes44.
PtdSer and other “eat-me” signals on apoptotic cells are also bound by opsonins such as
protein S, Gas6, and MFG-E8 (Table 1). These opsonins act to bridge these “eat-me”
signals efferocytic receptors such as the Tyro-3-Axl-MER (TAM, Table 1) family of
receptors and integrins such as αvβ3 and αvβ510, 11, 43. The signaling of these receptors has
not been elucidated, but they are known to play a central role in homeostasis in the eye45,
46

and in preventing autoimmune disorders such as lupus47. While not thoroughly

understood, it is likely that these opsonin-dependent receptors cooperate with the
receptors that directly bind to “eat-me” signals, culminating in fast and efficient
internalization of apoptotic cells.
Common signaling pathways driving apoptotic cell internalization
The signaling of most efferocytic receptors remains unknown, although recent studies
have provided some insights into functions of a small number of these receptors.
Interestingly, many of these studies have shown that integrin-mediated signaling is a key
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component of several efferocytic receptors34, 45 despite apoptotic cell binding is largely
dependent on non-integrin receptors. Outside of efferocytosis, integrins play major roles
in a wide range of biological activities including chemotaxis, adhesion, and phagocytosis.
All integrins are heterodimers composed of α and β subunits. Each subunit has a large
ligand-binding extracellular domain, a single membrane spanning domain and a short
lumenal domain which mediates integrin cell signaling via various tyrosine kinases and
adaptor proteins48. As described above, several apoptotic receptors interact with integrins
as co-receptors, and appear to utilize the integrin signaling pathway to mediate apoptotic
cell internalization. Integrins associated with efferocytosis include αvβ3 and αvβ5, with
siRNA-knockout of both integrins in macrophages decreasing efferocytosis by more than
60%34. Addition of antagonistic RGD peptides or anti-αvβ3 antibody also reduced
phagocytosis of apoptotic neutrophils by primary human macrophages to a similar
degree49. It is unclear at this time if the integrins normally associated with phagocytosis
(e.g. αMβ2) are involved in efferocytosis.
Upon integrin activation, FAK is activated by auto-phosphorylation and recruits Src
kinases via its Src-homology 2 (SH2) domain. Subsequent tyrosine phosphorylation on
FAK by Src kinases recruits CRK2-associated substrate (CAS) and phosphatidylinositol
3-kinases (PI3-K) to FAK10, 48, 49. Lastly CRK2 and dedicator of cytokine 180 (DOCK180)
are recruited to the FAK complex. Vav, a Ras GEF, is recruited to DOCK180-ELMO1
complex to activate Rac1. Active Rac1 and CDC42 together activate Arp2/3 which then
induces actin polymerization and cytoskeleton rearrangement. Ultimately, the resulting
actin remodeling induces formation of membrane protrusions which envelope and
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internalize the apoptotic cell10, 11, 34, 50. Once enveloped, Vav activates RhoA, which in
turn activates ROCK followed by activation of myosin light chain kinase. This drives
actin contraction through phosphorylation of the myosin light chain. The resulting actin
contraction pulls the enveloped apoptotic cell into the phagocyte, resulting in formation
of an efferosome. Because RhoA impairs actin polymerization it can negatively regulate
apoptotic cell internalization if active during the initial stages of envelopment. However,
when activated near the end of the envelopment stage, RhoA’s induction of actin
contraction is key for full internalization of the apoptotic cell and its subsequent
degradation11.

1.4 Phagocytosis as a Model of Efferocytosis
The signaling molecules and vesicular fusion events that mediate the degradation of a
phagocytosed apoptotic cell remain unexplored in the mammalian system. However,
previous studies in the nematode Caenorhabditis elegans suggests that the same
degradative pathway is responsible for degrading both efferosomes and phagosomes51, 52.
Phagocytosis is the process through which professional phagocytes internalize and
destroy pathogens, and is crucial to both innate and adaptive immunity52. Professional
phagocytes (e.g. macrophages and neutrophils) recognize and internalize and destroy
large particles, greater than 0.5 µm53. In addition to removing and degrading pathogens,
phagocytosis leads to the display of phagosome-derived antigens to peripheral lymphoid
cells and expression of pro-inflammatory cytokines. As such phagocytosis is proinflammatory and immunogenic, the opposite of efferocytosis. Despite the opposite
immunological outcomes, efferocytosis and phagocytosis appear to share some
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similarities in the cellular processes they use for degradation, and thus we used
phagocytosis as a guide for our investigations into efferocytosis.
Phagocytosis is a receptor-mediated process that can be driven by more than 20 different
pathogen binding receptors which allow refined immune reactions to different types of
pathogens10, 52. Indeed, some phagocytic receptors act as pattern-recognition receptors
(PRRs) which detect pathogen-associated molecular patterns (PAMPs) on bacteria, fungi
and parasites. For example, the phagocytic receptor dectin-1 binds β-glucans on fungal
pathogens10. Not all phagocytic receptors act as PRRs; some (e.g. FcγRI) instead bind to
pathogens via opsonins such as immunoglobulins (e.g. IgG), which in turn bind to surface
antigens on pathogens10. Once the pathogen engages the phagocytic receptors on
macrophages, the plasma membrane of the phagocyte is extended and envelops the
receptor-engaged pathogen, eventually drawing the pathogen into an intracellular
vacuolar structure that matures into a bactericidal compartment via fusion with
endosomes and lysosomes54. This is orchestrated by changes in membrane
phosphatidylinositol (PtdIns)-derived phospholipids and recruitment of regulatory
proteins that drive the step-wise maturation of nascent phagosomes into phagolysosomes.
First, early endosomes are recruited to the nascent phagosome by the Rab5 GTPase,
where they fuse with the nascent phagosome to form an early phagosome (Figure 1).
Rab5 is then replaced by Rab7, which mediates fusion between the phagosome and late
endosomes and lysosomes, forming a phagolysosome. A key component driving this
process at the early phagosome stage is Vps34, a class III phosphatidylinositol 3-kinase
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Figure 1: Rab GTPases mediated phagosome maturation
Once pathogens ( > 0.5 µm) are engulfed by macrophages, newly formed membranesealed phagosomes undergo step-wise maturation process mediated by Rab 5 and 7
GTPases, with subsequent changes in membrane phospholipids and lumenal pH. Each
maturation stage is associated with acidification from endosomal and lysosomal fusion,
wherein pathogens are degraded. Figure adapted from Dr. Heit.
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(PI3K). Vps34 phosphorylates phosphatidylinositol (PI) to form phosphatidylinositol-3phsophate (PI(3)P), which mediates further recruitment of early endosomes and their
fusion to early phagosomes10. PIKFYVE, a PI5-Kinase is recruited to, and then
phosphorylates PI(3)P to form PI(3,5)P252. This triggers the exchange of Rab5 for Rab7,
thus enabling fusion of the phagosome with late endosomes and lysosomes, and thus
driving transition of the phagosome first to a late phagosome and then to a
phagolysosome55. It is during this later stage of phagosome maturation where the bulk of
phagosome acidification occurs, thus activating the degradative enzymes delivered
through lysosomal fusion. The combined effect of acidification and degradative enzyme
activation kills the pathogens within the phagosome10, 51, 52.
The roles of Rab GTPases in endosome trafficking and phagosome maturation
The Rab GTPases (Ras-related protein in brain) is a group of small GTPases, composed
of over 60 members, that localize specifically to intracellular membranes56. Rab GTPases
cycle between active and inactive states when bound to GTP or GDP respectively10, 56.
Rab GTPase activation is mediated by guanine nucleotide exchange factors (GEFs) that
replace GDP for GTP, thus activating the Rab. Rab GTPases are crucial in delivery and
fusion of cellular component-containing vesicles between organelles. These GTPases
control traffic of these vesicular cargoes via several components: 1) SNARE complexes
control the specific membrane fusion, 2) Motor proteins (e.g. dynein/dynactin) transport
vesicles along the microtubular network, and 3) Cytosolic coat molecules that recruit
specific molecular components to vesicles. Inactivation of Rab proteins is mediated by
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GTPase-activating proteins (GAPs) that induce the hydrolysis of GTP to form GDP. An
additional protein, Rab GDP dissociation inhibitor (GDI), maintains the inactive form of
the GTPases, designates the delivery site of inactive Rab GTPases, and recycles
inactivated Rab to the cytosol10, 56, 57, 58.
Rab5 and 7 directly contribute to phagosomal maturation (Figure 1). The nascent
phagosome undergoes fusion with early endosomes where it acquires Rab5. Active Rab5
recruits Vps34 the class III PI3K that synthesizes PI(3)P, in turn recruiting additional
Rab5 effector proteins such as early endosome antigen 1 (EEA1)10. In yeast, Rab5
contributes to the Rab5 to Rab7 transition by recruiting a Rab7 GEF, composed of Mon1
and Ccz1, but their functions in mammalian system are not well-elucidated59. Rab7
replaces Rab5 in the transition state from early phagosomes to late phagosomes. In the
end, Rab7-interacting lysosomal proteins (RILP) and the long splice-variant of oxysterolbinding protein related-protein1 (ORP1L) are recruited by Rab7 to late phagosomes
where they act as Rab7 effectors. These Rab7 effectors induced linkages between
microtubule proteins and phagosomes, driving the movement of the phagosome to the
perinuclear area where they undergo fusion with lysosomes and late endosomes, thus
forming phagolysosomes52. Lysosome-associated membrane proteins 1 and 2 (LAMP-1
and -2) are also significant late phagosomal membrane proteins, which are critical for
Rab7 recruitment and preservation of lysosomal membrane integrity52. A recent study of
Rab34 has shown that Rab34 also localizes to phagosomes where it is involved in the
size-dependent delivery of cargo from late endosomes and lysosomes. Specifically,
Rab34, accompanied by its effector Munc 13-2, aids in the delivery of large (>70kDa)
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lysosomal contents to the maturing phagosome in Rab7 independent manner60. In
summary Rab GTPases are crucial in regulating the membrane traffic and vesicular
fusion that drives phagosome maturation, and enable the step-wise maturation of the
phagosome through sequential fusion with early endosomes, late endosomes and finally
lysosomes.
Phagosome acidification and recruitment of degradative enzymes
As phagosomes undergo maturation they reduce their passive proton permeability10. At
the same time Rab5 and Rab7 mediated vesicular fusions deliver vacuolar ATPases (VATPases) to maturing phagosomes. This V-ATPase pumps protons from the cytosol into
the phagosome, leading the phagosome to acidify as it matures into a phagolysosome.
The phagosomes begins with the same pH as the intracellular milieu (~7.4), drops to a pH
of 6.5 in the early phagosome stage, and reaches a pH of 4.5 by the phagolysosome
stage10, 61. This thousand-fold increase in proton concentration cannot be achieved
passively, and instead requires active pumping by the V-ATPase.
The resulting acidity activates many pH-dependent degradative enzymes such as
cathepsins, lipases, and other lysosomal acid hydrolases, which degrade the pathogen10, 19.
This pH drop is also important for antigen presentation on MHC II molecules, as
activation and loading of MHC II is driven by an acid-dependent protease that cuts the
invariant chains that retains MHC II in an unloaded conformation. A recent study has
shown that polarized macrophages such as M1 and M2 cells undergo different NADPH
oxidase production18. In addition, a study of dendritic cells and M0-like bone marrow
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derived murine macrophages showed different superoxide production by NADPH
oxidase alter the phagosomal pH through consumption of phagosomal protons to form
H2O262, 63. Thus it is predictable that phagosomes of M1 macrophages acidify slower and
to a lesser extent than M0 or M2 macrophages due to their higher NADPH oxidase
activity. Importantly, pro-inflammatory cytokines such as IFN-γ and PAMPs such as LPS
not only stimulate the polarization of macrophages into M1 cells but also induce NADPH
oxidase expression, suppressing the rate of acidification in the phagosomes of M1 cells.
In contrast, M2-like macrophages, with similar low NADPH oxidase activity as M0-like
macrophages, express fewer components and lower levels of the NADPH oxidase
complex that may allow for faster acidification and a lower terminal pH18, 62. Expected
prompt acidification in M2 cells may also leads to rapid cargo degradation which appears
to degrade proteins before antigens can be loaded onto MHC II, preventing activation of
the adaptive immune system. In contrast, the slow acidification of M1 phagosomes leads
to stronger antigen presentation. While this presentation is important following the
phagocytosis of a pathogen, the increased NADPH oxidase activity in M1 cells may
produce oxidized self-antigens derived from apoptotic cells cargo’s, potentially leading to
autoimmune antigen presentation18, 19. In summary, phagosome acidification contributes
to many phagosomal functions, including not only activation of the phagosomal
degradative pathways, but also in regulating antigen presentation and perhaps in the
formation of autoantigens.
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1.5

Known Efferocytic Maturation Mechanisms

While the efferocytic maturation process is not as well understood as the phagocytic
process, some of the mechanisms have been studied in the C. elegans nematode model51.
This study explored efferosome maturation in C. elegans and determined that it proceeds
through a pathway similar to that of phagocytosis. In C. elegans, many cells undergo
apoptosis during the nematode developmental processes. Evolutionarily, C. elegans and
mammalian system share a common receptor-mediated signaling pathway that activates
CED-10/Rac, leading to a phagocytosis-like internalization processes in which membrane
ruffles and protrusions engulf apoptotic cells. Common phagosome maturation markers
such as Rab5 and Rab7 GTPases were found to be recruited to C. elegans efferosomes in
the same order and with similar time as with phagosomes51. The apoptotic cell containing
efferosomes recruited Rab5 and Rab5 effectors such as VPS-34. Rab7 was recruited at
later time points, replacing Rab5 on the efferosomal membrane without co-localization51.
Unlike mammalian phagocytosis, in C. elegans Rab5 was required for internalization,
with the Rab5 knockout causing an accumulation of non-internalized apoptotic cells. In
contrast, Rab7 knockout allowed for maturation to progress to the Rab5 step, but
eventually the buildup of non-degraded apoptotic cells inhibited further uptake, leading to
a block in apoptotic cells internalizaiton51.
In contrast, our preliminary results using RAW264.7 murine macrophages showed a
prolonged accumulation of Rab5 on efferosomes that contained apoptotic thymocytes and
red blood cells (data not shown, by Dr. Bryan Heit), a finding also observed by other
groups in dendritic cells64, 65. In our experiments, PI(3)P was retained on efferosomes,
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further indicating a lack of Rab5 to Rab7 transition. This suggested that the efferosome
maturation process in mammalian cells was different from that used by C. elegans.
Because of these distinct differences in efferosome maturation we became very interested
in how the efferocytosis maturation pathway differed from phagocytosis, especially in
how this altered processing impacts antigen presentation and inflammation in the
mammalian system.

1.6

Efferocytic Defects and Disease

The importance of efferocytosis in maintaining homeostasis is emphasized in diseases
where efferocytosis is defective. Generally apoptotic cells maintain membrane integrity
and are efficiently efferocytosed by professional phagocytes without releasing any
intracellular components. For example, the majority of developing thymocytes in the
thymus become apoptotic, and yet it is nearly impossible to detect uncleared apoptotic
thymocytes due to the high rate of efferocytosis by resident macrophages66. Deficiencies
in efferocytic receptors such as CD93 lead to the accumulation of apoptotic cells in the
thymus67, which would then be expected to lose membrane integrity and release their
intracellular components through a process termed secondary necrosis. Some of the
released cellular components can engage TLR and other pro-inflammatory receptors68.
These components, termed alarmins, include proteins such as the nuclear protein highmobility group box1 (HMGB1) as well as metabolites such as ATP3. In addition,
secondary necrosis releases self-proteins which may be endocytosed by phagocytes, and
due to the pro-inflammatory nature created by the simultaneous release of alarmins, may
be presented as autoantigens along with immunostimulatory cytokines and co-stimulatory
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molecules. Indeed, this release of self-antigens and alarmins from uncleared thymocytes
in CD93 knockout mice causes an autoimmune diseases similar to systemic lupus
erythematous (SLE)3. Mutations in a number of efferocytic receptors are associated with
the onset of SLE and other autoimmune diseases, highlighting the importance of
efferocytosis in maintaining immune homeostasis67, 69.
In addition to autoimmunity, failures in efferocytosis can lead to the development of
chronic inflammation such as atherosclerosis. During atherosclerosis macrophages in the
arterial wall become apoptotic in response to the uptake of large quantities of cholesterol.
Normally, these apoptotic macrophages are efferocytosed by neighbouring macrophages.
However, for unknown reasons in some people this homeostatic process fails, leading to
the accumulation of uncleared apoptotic macrophages in the vascular intima70. In some
patients these defects are induced by inherited mutations in efferocytic receptors and their
opsonins (e.g. MerTK, MFG-E8)71, 72. These uncleared apoptotic macrophages become
necrotic, accumulating over time to form an atherosclerotic plaque. This structure is weak
and prone to rupture - the resulting thrombus can dislodge, potentially evoking an acute
myocardial infarct or ischemic stroke66. Clearly, successful apoptotic cell clearance is
beneficial not only to homeostasis, but also in preventing clinically important
autoimmune and inflammatory diseases.

1.7 Rationale
The preliminary results from our lab, as well as the work with dendritic cells by
Ackerman et al.64 and Jancic et al.65 suggest that efferocytosis proceeds through a
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maturation process unique from that utilized by phagocytosis. This study aims to
elucidate the maturation process of efferocytosis in mammalian cells, with a focus on the
role played by the vesicular trafficking system during efferosome maturation and
identifying of potential unique protein regulators found on efferosomes. I believe that a
unique maturation process is required to maintain homeostasis through preventing the
efferosome from maturing into the same pro-inflammatory and immunogenic
compartment as the phagosome. Indeed, evidence suggest that defects in efferocytosis
cause or promote several chronic inflammation and autoimmune diseases, suggesting that
the normal efferocytic process is inherently non-inflammatory66. In this study we will use
murine and primary human macrophages to elucidate the molecular pathway regulating
the maturation process of efferosomes and to identify unique protein regulators found on
efferosomes versus phagosomes.

1.8 Hypothesis and Aims
Because efferocytosis and phagocytosis have different inflammatory and immunogenic
outcomes, I hypothesized that phagocytic and efferocytic maturation pathways are
regulated by fusions with different intracellular compartments, and that these fusion
events are regulated by novel mediators recruited either to phagosomes or to efferosomes.
To investigate my hypothesis, I proposed the following research aims:
Research Aim 1. Establish an in vitro macrophage model of efferocytosis.
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Rationale: Macrophages engulf apoptotic cells in a receptor-dependent manner, but these
receptors are differentially expressed on different macrophage subtypes. To ensure
consistent and reproducible results, I: 1) Identified macrophage cell lines and
differentiated primary human macrophages subtypes with high efferocytic capacity, and
2) Developed reproducible cell-based and bead-based efferocytic targets that were
employed in later aims.
Research Aim 2: To characterize the acquisition of common maturation markers
(i.e. Rab5, Rab7, LAMP-1) on efferosomes.
Rationale: The Rab GTPases Rab5 and Rab7 are critical regulators that direct
remodeling phagosomes and endosomes. However, the role of these Rab proteins in
efferocytosis is poorly understood in mammalian cells. By assessing the recruitment of
Rab5 and Rab7, as well as the recruitment of other markers of key vesicular
compartments, we can address the role of these proteins in efferosome maturation. One
key marker is LAMP-173, a well-known marker found in late endosomes and lysosomes.
Lysosomal fusion to phagosomes can be confirmed via immunostaining of LAMP-1 or
by following maturation in cells transfected with fluorescent LAMP-1. Together, tracking
these markers will characterize the role of these regulators on efferosome maturation.
To address this aim, I: 1) Tracked the recruitment of Rab5 and Rab7 on efferosomes. 2)
Tracked LAMP-1 recruitment to efferosomes to determine if lysosomal fusion was
occurring.
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Research Aim 3: To identify proteins that influence efferosome maturation through
an unbiased mass spectrometry based approach.
Rationale: Since we expect efferosome maturation to occur through a novel maturation
pathway, it is insufficient to merely test known regulators, and as such an unbiased
approach is needed to identify any novel regulatory factors. To identify these unique
proteins, mass spectrometry analysis of isolated efferosomes and phagosomes was
performed. To accomplish this aim I: 1) Recovered efferosomes using phospholipidcoated silica-magnetic beads as apoptotic cell mimics, and 2) Identified several novel
maturation regulators on the purified efferosomes and phagosomes using mass
spectrometry.
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Chapter 2 – Materials and Methods
2.1 Cell Line Culture and Human Macrophage Isolation
Human Jurkat T cells (gift from Dr. Lina Dagnino, Department of Physiology and
Pharmacology, Western University) and murine macrophage cell line J774.2 (ATCC)
were cultured at 37 °C in 5% CO2 in RPMI 1640 with 10% fetal bovine serum (FBS) (all
from Wisnet). RAW264.7 cells were cultured in DMEM + 10% FBS. Cultures were split
when they reached 80% of confluence. For phagocytosis and efferocytosis assay, 5 x 105
J774.2 or RAW264.7 cells were cultured on sterile coverslips.
Human primary monocytes were isolated from blood donated by healthy donors between
the ages of 18 and 65. Blood was collected in the lab under approval from Western
university’s Health Science Research Ethic Board using methods meeting the guidelines
of the Tri-Council Policy Statement on human research. Blood was layered over an equal
volume of lympholyte poly (Cedarlane), and centrifuged at 500 x g for 35 minutes at
22 °C. The top cell layer of peripheral blood mononuclear cell (PBMC) was collected and
washed with PBS. Monocytes were separated from PBMC by adhesion to glass or plastic
surface - PBMC’s were resuspended in RPMI 1640 (300 µl /well). For phagocytic assays,
300 µl of suspension was added to a sterile 18mm diameter coverslips placed into a well
of a 12-well tissue culture plate and incubated at 37 °C in 5% CO2 for 1 hour. Nonadherent (non-monocyte) PBMC’s were removed by a wash with 37 °C PBS. 1ml of
RPMI 1640 with cytokines (see below) was added to each well. For mass spectrometry a
total of 3.6 ml PBMC suspension was added to a 1-well gelatin-covered plate. An hour
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later non-adherent cells were removed by washing as above and 12ml of RPMI 1640 with
cytokines (see below) was added to each plate.

2.2 Primary Human Macrophage Differentiation
Adherent monocytes were differentiated over 7 days into each subtype of macrophages
through the addition of specific cytokines. M0 macrophages were differentiated by the
addition of M-CSF (10 ng/µl) alone for 7 days. M1 macrophages were differentiated in
GM-CSF (20 ng/µl) for 5 days followed by the addition of IFN-γ (10 ng/ml) and LPS
(250 ng/ml). M2 macrophages were cultured in M-CSF (10 ng/μl) followed by the
addition of IL-4 (10µg/ml) on day 5. All cells completed differentiation on day 7 and
remained viable until day 1074.

2.3 Induction of Jurkat T Cell Apoptosis and PtdSer Flipping
Apoptosis was induced in Jurkat T cells by treating 2.5 mM staurosporine (STS) in RPMI
1640 and incubated at 37 °C in 5% CO2 for 2.5 hours. Jurkat T cells were then washed
three times with PBS at room temperature and then resuspended to 1ml of PBS. Annexin
V (1/1000, eBioscience) was added to Jurkat T cells in 1 ml of imaging buffer (25 mM
HEPES, 0.8% NaCl, 5.4 mM KCl, 1.3 mM CaCl22H2O, and 1mM MgCl2 in 100ml
ddH2O with pH 7.4) and incubated for 5 minutes, followed by three washes in PBS with
2.5 mM CaCl2 at room temperature and then resuspended in 1 ml of imaging buffer. To
flip PtdSer independently of apoptosis, Jurkat T cells (no STS) were treated with 10 µM
ionomycin (Fisher Scientific) and stained with annexin V as above. Untreated Jurkat T
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cells were stained with annexin V (1/1000) in 1 ml of imaging buffer as above. Images of
all Jurkat cells were acquired using the protocol described in section 2.8.

2.4 Induction of Neutrophil Apoptosis
The polymorphonuclear neutrophil layer (lower band of cells produced during the density
gradient centrifugation in method 2.1) was collected and washed with PBS at 4 °C. PBS
was aspirated gently and the neutrophils quickly and gently resuspended in 12ml ice cold
water for 20 seconds to lyse remaining red blood cells. Lysis was stopped after 20
seconds by the addition of 4 ml of 0.6 M KCl solution. Neutrophils were washed with
PBS a second time and resuspended in 2 ml of RPMI 1640 + 10% heat-inactivated
autologous serum. Apoptosis was induced by heat-shocking the cells at 43 °C for 45 min,
followed by an incubation at 37 °C in 5% CO2 for 3 hours for recovery75. Necrosis was
induced by heating the neutrophils at 55°C for 1 hour. After washing with PBS twice,
apoptotic/necrotic neutrophils were suspended in RPMI 1640 and labeled with eFlour670
cell proliferation dye (5 mM, eBioscience) to identify them in efferocytosis assays.
Apoptosis and necrosis were detected by co-staining of annexin V and propidium iodide
in imaging buffer at 37°C for 5 min.

2.5 Preparation of Synthetic Phagocytic and Efferocytic
Targets
Silica and magnetic beads were coated with lipids and IgG in order to prepare beads that
function as apoptotic mimics and phagocytic targets respectively76. Lipid-coated beads
were prepared using silica beads (3.14 µm, Bangs Laboratories) or silica-coated magnetic
beads (5µm, Bioclone) in order to non-covalently attach a bilayer of phosphatidylserine
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(PtdSer: 19.8%), phosphatidylcholine (PtdCho: 80%) and biotinylated
phosphatidylethanolamine (Biotin-PtdEtn: 0.2%, all lipids from Avanti Polar Lipids).
Control beads were prepared using the same mixture minus the PtdSer. The mixture of
silica beads and lipids were dried under nitrogen gas for 1 hour. Lipid coated beads were
then suspended with 20 mM Tris-HCl pH 7.4 and washed multiple times with PBS. For
mass spectrometry, magnetic beads were coated only with PtdSer (20%) and PtdCho
(80%) to prepare apoptotic targets. IgG coated beads were prepared by mixing the same
silica or silica-coated magnetic beads as above with purified human IgG antibodies
(Sigma). 20 µl of human IgG were coated onto 300 µl of silica/silica-coated magnetic
beads in PBS. The mixture was incubated for 1 hour at room temperature, washed once
with PBS, and kept at 4 °C until use.

2.6 Transfection
J774.2 and RAW264.7 cells were cultured at 5×105 per coverslips and incubated at 37°C
with 5% CO2 overnight. 3µg of plasmid DNA (mouse pmGFP, mouse Rab5-eGFP,
mouse Rab7-pmCherry, mouse Rab7-eGFP) was mixed with 100 µl of serum-free RPMI
1640 and 9 µl of FuGene-HD (Promega) transfection reagent added. This mixture was
incubated for 15 min at room temperature according to the manufacturer’s manual. The
mixture was added drop-wise to a single well of cells in a 12-well plate, and the cells
were incubated overnight before use.
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2.7 In Vitro Phagocytic and Efferocytic Assay
J774.2, RAW264.7, and ANA-1 cells were cultured on coverslips in 12-well plates and
transfected with pmGFP, Rab5-eGFP, Rab7-pmCherry or Rab7-eGFP. Primary
macrophages were cultured on coverslips in 12-well plates without transfection.
Apoptotic neutrophils and PtdSer-coated silica beads were prepared as described in 2.4
and 2.5 and utilized as apoptotic targets. IgG-coated silica beads were prepared as
described in 2.3 and utilized as phagocytic targets. 1×106 of neutrophils, PtdSer-coated
silica beads, PtdCho-silica beads or IgG-coated silica beads in 200 µl of RPMI were
added to each well of macrophages, centrifuged at 1500 rpm for 1 minute, at 4°C, and
then incubated at 37°C for 10 to 30 minutes. Each well was then washed with PBS three
times and fixed with 4% PFA. Wells with PtdSer-silica beads and PtdCho-silica beads
were labeled with fluorescent-conjugated streptavidin (1/1000). Wells with neutrophils
were blocked in blocking buffer (0.5% skim milk in PBS) for 30 minutes and then,
stained with mouse anti-human CD18 antibody (1/500, Developmental Studies
Hybridoma Bank) and goat-anti-mouse secondary fluorescent conjugated antibody (1/500,
Jackson Laboratories) for 30 minutes. Wells with IgG-coated silica beads were stained
with a fluorescent-conjugated anti-mouse Fab secondary antibody (1/500, Jackson
Laboratories).

2.8 Confocal and Fluorescent Microscopy
Confocal images were captured using a Leica TCS SP5 II scanning confocal microscope
(Robarts Research Institute) equipped with HeNe1/2 and Argon/2 lasers and a
60X/1.20NA objective. Widefield fluorescent images were captured using an Olympus
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IX-70 microscope equipped with a 60X/0.9NA phase contrast objective running
μManager software77.

2.9 Calculation of Phagocytic Index
Lipid-coated or IgG coated beads were added to wells containing cultured macrophages,
1 x 106 beads per well in a 12-well plate, and then centrifuged at 1500 RPM for 1 minute
at 4°C and then incubated at 37°C for 30 minutes. After washing with PBS twice, noninternalized beads were stained with streptavidin (1/1000) or goat-anti-mouse Fab-Cy5
(1/500) at 37°C for 5 minutes. Macrophages were washed with PBS twice, and then fixed
with 4% paraformaldehyde (PFA) for 30 minutes. Phase-contrast and fluorescence
images of the efferocytic assays were captured as per method 2.8. Images were analyzed
with Image J (NCBI) to count internalized beads per each macrophage in the field of
view. A minimum 40 macrophages were analyzed per experiment. Phagocytic index of
macrophages was calculated by dividing the total number of internalized beads by total
number of macrophages.

2.10 Efferosome and Phagosome Isolation
M0 macrophages were cultured on gelatin-covered tissue culture plates for 7 days as
described in 2.1 and 2.2. PtdSer-magnetic beads and IgG-magnetic beads in 3ml of RPMI
were added to each plate of M0 macrophages. M0 macrophages efferocytosed (PtdSermagnetic beads) and phagocytosed (IgG-magnetic beads) for 40 min at 37 °C, then
treated with ReCLIP reagent (Reverse Cross-Link Immuno-Precipitation, 1:1 mix of
Dithio-bismaleimidoethane and Dithiobis[succinimidyl propionate) for 30 minutes at
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room temperature78. ReCLIP solution was then aspirated and 10 ml of a quenching
solution (20mM of Tris-Cl pH 7.4 and 5mM of L-Cysteine) was added and incubated at
room temperature for 10 min. Macrophages were then washed with PBS, placed on the
ice and scrapped into 10ml of lysis buffer (Table 3). Suspended macrophages were then
lysed using a nitrogen bomb, 10 minutes at 300 psi, on ice. A magnetic column was used
to recover magnetic beads-containing efferosomes and phagosomes. Efferosomes and
phagosomes were washed three times with 1ml of wash buffer (Table 2) and recovered
using a magnetic column. Efferosomes and phagosomes were solubilized in 30 µl 1X
Laemmli buffer (from 4X Laemmli buffer with 2.4 ml of 1 M Tris pH 6.8, 0.8 g of SDS
stock, 4 ml of 100% Glycerol, 0.01% of Brombophenol blue, and 2.8 ml of ddH2O) with
protease/phosphatase inhibitors (Fisher Scientific) and 50 mM DTT (Fisher Scientific),
incubated at 37°C for 30 min to reverse the ReCLIP crosslinking, and then boiled for 5
min to denature the proteins for SDS-PAGE.

2.11 SDS-PAGE and Coomassie Staining
Phagosome and efferosome isolates from 2.10 were separated using 4-20% MiniPROTEIN gel (Bio-Rad) for approximately 2 hours at 100 V. Gels were fixed (40%
ethanol and 10% of glacial acetyl acid) followed by a quick wash with clean water, then
stained with coomassie blue (Bio-Rad) for 20 hours. Gels were then destained in clean
water for 3 hours. Destained protein gels were imaged on a protein gel tray of the GelDoc
EZ imager (Bio-Rad) to visualize recovered proteins. Gels were stored in clean water
prior to mass spectrometry.
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2.12 Mass Spectrometry Analysis
Protein bands on coomassie gels were picked into 96-well plates by an Ettan Robotic
Spot-picker machine located in the functional proteomics facility (Department of
Biochemistry, Western University). Gel slices were destained with 50 mM ammonium
bicarbonate and 50% acetonitrile, treated with 10 mM DTT and 55 mM iodoacetamide,
and then digested with trypsin. Peptides were extracted by a solution of 1% formic acid
and 2% acetonitrile and freeze dried. Dried peptide samples were then resuspended in a
solution of 10% acetonitrile and 0.1% trifluoroacetic acid. Mass spectrometry analysis of
each sample was performed using an AB Sciex 5800 TOF/TOF System, MALDI
TOF/TOF (Framingham, MA, USA) by Kristina Jurcic (MALDI facility manager). Raw
mass spectrometry data analysis was performed using MASCOT database search
(http://www.matrixscience.com). Proteins were then divided into groups based on their
protein scores.

2.13 Statistical Analysis
GraphPad prism software was used for all tests. Unless otherwise noted a one-tailed
unpaired student t-test was used for analysis. Data are presented as mean ± standard error
of the mean. p values ≤ 0.05 are considered to be significant and are indicated by *.
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Table 2: Wash buffer used for efferosome and phagosome isolation
Ingredient Concentration (mM)
Sucrose

250

HEPES

10

MgCl

3

NaVO4

1

Table 3: Lysis buffer used for efferosome and phagosome isolation
Ingredient

Amount

Wash buffer (Table 1)

1 ml

Protease/phosphatase inhibitors

1:100 dilution*

DNAse I

1: 50 dilution*

PMSF

0.25 mM

Okadaic acid

200 nM

NaF

10 mM

* Dilution of commercially provided stock
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Chapter 3 – Results
3.1 Optimized In Vitro Efferocytosis Assay of Apoptotic
Neutrophils
To ensure reproducible efferocytosis, I needed to establish efficient and reproducible
methods to generate apoptotic targets. Initially I selected immortalized human Jurkat T
cells, treated with staurosporine, as apoptotic targets. Jurkat T cells have been widely
used because of their small size and they are easy to culture79. Previous studies used
staurosporine, a general inhibitor of cellular serine/threonine kinase, to induce apoptosis
in these cells via a caspase 9 dependent pathway80. Annexin V staining was used to
confirm that PtdSer was being flipped to the outer leaflet of the apoptotic cells plasma
membrane81 and images of apoptotic Jurkat T cells were acquired by widefield
microscopy. As a positive control I used ionomycin, a Ca2+ ionophore, to induces PtdSer
exposure independent of apoptosis82. As expected, ionomycin treated Jurkat T cells
stained strongly with annexin V (Figure 2A). Apoptotic Jurkat T cells also stained with
annexin V (Figure 2B), whereas control Jurkat T cells were negative for annexin V
staining (Figure 2C). However, staurosporine generated a low yield of apoptotic cells
after 2.5 hours, and longer incubation periods were avoided in order to prevent the
formation of necrotic cells. This data demonstrates that PtdSer can be used to detect
apoptosis in our model systems, but staurosporine was inefficient to produce apoptotic
targets.
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Figure 2: Staurosporine (STS) induction of apoptosis in Jurkat T cells.
The apoptosis marker PtdSer was stained on Jurkat T-cells using fluorescent annexin V
(red). A) PtdSer flipping was induced in Jurkat T cells with ionomycin. Scale bar = 20
µm. B) PtdSer flipping was observed on cells in which apoptosis was induced with STS.
C) No PtdSer flipping was observed on untreated cells. Jurkat T cells are marked by
arrows. Images are representative of 3 images, taken over 3 independent experiments.
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I then tested an alternative method that has been used in the literature to reliably produce
a large percentage of apoptotic cells without significant necrosis. This model utilizes
heat-shocked human neutrophils. Human neutrophils undergo rapid apoptosis in a
caspase-dependent manner by the heat-shock treatment (>40°C)83. Using the method of
Park et al.75, (details in Section 2.4) I achieved a stronger induction of apoptosis with a
high yield (>40%) of apoptotic neutrophils without producing overt signs of secondary
necrosis such as cell fragmentation. As expected, apoptotic neutrophils were annexin V
positive and propidium iodide negative, indicating the absence of significant necrosis
(Figure 3A). The positive staining control, necrotic neutrophils, stained with both annexin
V and propidium iodide (Figure 3B). Because the method of Park et al. provided high
rates of apoptosis in neutrophils without necrosis it was used for all future experiments
requiring apoptotic cells.
Next I assessed the efferocytic capabilities of the J774.2, RAW264.7 and ANA-1 murine
macrophage cell lines. Prior to the efferocytosis assay, I transfected these cells with
plasma membrane tagged GFP (pmGFP) to identify efferosomes through the formation of
a GFP+ (e.g. plasma membrane-derived) intracellular vacuole84. These cells then became
apoptotic neutrophils that were pre-labeled with the fluorescent cell tracer eFluor670. At
the end of the experiment non-efferocytosed neutrophils were labeled with an anti-human
CD18 antibody and Cy3-conjugated secondary antibody. Negative immunostaining of
CD18 indicates that a neutrophil was completely engulfed. Images of J774.2 cells, were
acquired by confocal microscopy and revealed a number of neutrophil-containing
vacuoles with GFP in their bounding membrane, indicating efferocytosis had occurred
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Figure 3: Generation of apoptotic neutrophils by heat-shock.
Apoptosis and necrosis was induced in human polymorphonuclear neutrophils by heatshock, and the cells stained with annexin V (green, merged channel) and propidium
iodide (red, merged channel). A) Apoptotic neutrophils stained with annexin V but not
propidium iodide. Scale bar = 10 µm. B) Necrotic cells stained with both annexin V and
propidium iodide. Image is representative of 3 images, taken over 3 independent
experiments.
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Figure 4: J774.2 cells efferocytose apoptotic neutrophils.
J774.2 macrophages were transfected with pmGFP (green) and efferocytosed eFlour670labeled apoptotic neutrophils (red). Non-efferocytosed neutrophils were labeled with antiCD18 (cyan). Insert highlights an efferocytosed neutrophil which is CD18-negative, and
surrounded by a pmGFP-positive bounding membrane. Image is representative of 15
images, taken over 3 independent experiments. Scale bar = 10 µm.
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within 10 minute timeframe of the assay (Figure 4). All neutrophils observed in GFP+
compartments were not labelled with anti-CD18, demonstrating that J774.2 cells
efficiently and completely internalized the apoptotic cells. Similar experiments were
performed with ANA-1 and RAW264.7 cells, however these cells have extremely low
levels of efferocytosis (less than 1 neutrophil engulfed per field of view (~20 cells), data
not shown) and were not be used for future experiments.

3.2 Optimized In Vitro Efferocytosis Assay of Synthetic
Apoptotic Targets
Although apoptotic human neutrophils were efferocytosed, the number of efferocytosed
apoptotic cells was limited (~0.5/transfected J774.2 cell). Moreover, neutrophils were not
always available due to limited blood donors. As such it was necessary to generate
apoptotic cell mimics that would be consistently efferocytosed in greater numbers and
which could be prepared as needed. I took a bead-based approach which is commonly
used in studies of phagocytosis and efferocytosis, and which is established to generate
more stable and reproducible phagocytic/efferocytic targets34, 76. Silica beads were coated
with phospholipids to mimic plasma membranes of apoptotic cells by coating them with a
mixture of PtdSer (20%) and PtdCho (80%). If required, 0.2% of the PtdSer could be
replaced with biotinylated phosphatidylethanolamine (Biotin-PtdEtn) to allow detection
of non-internalized beads with fluorescent streptavidin76. To ensure that efferocytosis is
PtdSer specific, control beads containing PtdCho (with or without Biotin-PtdEtn) were
also prepared. pmGFP transfected J774.2 cells efficiently internalized these apoptotic
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Figure 5: J774.2 cells efferocytose apoptotic cell-mimicking beads.
pmGFP-expressing J774.2 macrophages (green) were fed PtdSer/PtdCho or PtdCho
(negative control) coated beads. Streptavidin (red) was used to detect non-internalized
beads. A) J774.2 macrophages efferocytosed apoptotic cell mimics (arrows). B) J774.2
cells did not phagocytose PtdCho beads. Scale bars = 10 µm. C) Phagocytic index of
J774.2 cells efferocytosing apoptotic cell mimics. Data shown at means ± SEM, n=4. **,
p<0.05.
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cell mimics but not the control (PtdCho) beads (Figure 5A). Efferosomes that were
surrounded by a ring of GFP were not marked with streptavidin, indicating they were
internalized into a membrane-bound compartment within the macrophage. Partially
internalized and surface bound PtdSer-coated beads labeled with fluorophore-conjugated
streptavidin (Figure 5A). The efferocytic capacity (phagocytic index) of J774.2 cells was
calculated by dividing the total number of internalized beads by the total number of
J774.2 cells. On average two PtdSer-coated beads were efferocytosed per J774.2,
whereas no PtdCho coated beads were internalized (Figure 5B). This data demonstrates
that these apoptotic mimics are a viable alternative to apoptotic neutrophils.

3.3 In Vitro Efferocytosis by Primary Human Macrophages
Because cell lines are prone to mutations that impact in downstream cellular processes,
we wished to establish an efferocytosis assay using primary human macrophages. To
accomplish this I quantified the efferocytosis ability of primary human macrophages
differentiated to the three main subtypes of macrophages. M0 macrophages (cultured
with M-CSF alone) are fully matured but non-polarized macrophages. M1 macrophages
(cultured with GM-CSF, IFN-γ and LPS) and M2 macrophages (cultured with M-CSF
and IL-4) are highly pro-inflammatory macrophages and anti-inflammatory/tissue healing
macrophages respectively12, 17. Each subtype was fed PtdSer-coated or PtdCho-coated
beads for 30 minutes and imaged by fluorescent microscopy to calculate phagocytic
index.
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M0 macrophages readily internalized PtdSer-coated beads whereas no PtdCho-coated
beads were engulfed (Figure 6). M1 macrophages did not internalize many beads, and
internalized both PtdSer and PtdCho beads with equal efficiency (Figure 6), suggesting
that this uptake was non-specific. M2 macrophages actively efferocytosed PtdSer-coated
beads but to a lesser extent than M0 macrophages (Figure 6). This data suggests that M0
and M2 macrophages are effective in internalizing apoptotic cells, while M1
macrophages are not. However, as M0 cells had the highest efferocytic capacity, we
selected them for use in future aims.
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Figure 6: Efferocytosis by primary human macrophages
Human monocytes were differentiated into M0, M1 and M2 macrophages. Polarized
macrophages were fed PtdSer-coated beads and PtdCho-only coated beads, and the
phagocytic index was quantified. n = 4, **, p < 0.05 compared to PtdCho-only beads.
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3.4 Efferosomes Acquire Rab5 and Rab7 Similarly to
Phagosome Maturation
Using the highly effective bead-based model, I next assessed the role of Rab5 and Rab7,
phagosome maturation regulators, in efferosome maturation using J774.2 cells.
Specifically, I assessed whether both phagosomes and efferosomes recruited these
common regulators of phagosome maturation as the C. elegans studies51, or if
efferosomes only recruit Rab5 as suggested by our preliminary results and the dendritic
cell studies64, 65. To this end I tracked ectopically expressed GFP- or mCherry-tagged
Rab5 and Rab7, which demark early and late stages of maturation respectively10, 52, in
J774.2 cells engulfed IgG-coated or PtdSer-coated beads. Phagocytosis of IgG opsonized
beads was used as a positive control, and exhibited the expected pattern of Rab5/Rab7
acquisition wherein Rab5 was recruited at 10 minutes and replaced at later time points by
Rab7 GTPases (Figure 7, 11A). By 20 minutes most phagosomes were Rab5 negative
and had acquired Rab7, with Rab7 completely replacing Rab5 on the phagosomes by 30
minutes (Figure 7, 11A). This data confirms that J774.2 cells demonstrate normal
phagosome maturation, with dynamics similar to that reported in other types of
macrophages51.
This assay was repeated using apoptotic cell mimics (Figure 8, 11B). By 10 minutes
efferosomes had recruited Rab5 GTPases, but the Rab5 began to disappear at 20 minutes,
with Rab5 completely lost from the efferosomal membrane by 30 minutes (Figure 8,
11B). Rab7 began to appear on the efferosomal membrane as early as at the 10 minute
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time-point, with significant recruitment observed at 20 minutes. Rab7 entirely replaced
Rab5 on the efferosome membrane by 30 minutes (Figure 8, 11B).
To confirm that the observed patterns of Rab acquisition were not due to artefacts created
by using lipid-coated beads we repeated these experiments using apoptotic neutrophils.
Apoptotic neutrophils were readily internalized, and the resulting efferosomes positive
for Rab5 by the 10 minute time-point, with the Rab5 displaced within 20 minutes (Figure
9, 11C) and replaced by Rab7 (Figure 10, 11C). Rab5 was completely supplanted from
the efferosome by Rab7 after 30 minutes (Figures 9, 10, 11C). The acquisition of Rab5
and Rab7 during efferocytosis in both the bead-based and cell-based strongly suggests
this is a bona fide result and not an artefact of the apoptotic bead model.
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Figure 7: Tracking Rab5 and Rab7 on phagosomes
Rab5-GFP (green) /Rab7-mCherry (red) transfected J774.2 cells were fed IgG-coated and
imaged at various time points. Non-internalized beads were labeled with the fluorophoretagged secondary antibody (magenta). Image is representative of 20 images, taken over 3
independent experiments. Scale bars = 5 µm.
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Figure 8: Tracking Rab5 and Rab7 on efferosomes
Rab5-GFP (green)/Rab7-mCherry (red) transfected J774.2 cells were fed PtdSer-coated
beads and imaged at different time points. Non-internalized beads were labeled with
streptavidin (magenta) at the end of the experiment. Image is representative of 20 images,
taken over 3 independent experiments. Scale bars = 10 µm.
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Figure 9: Rab5 recruitment to apoptotic-neutrophil containing efferosomes.
Rab5-GFP transfected (green) J774.2 cells efferocytosed apoptotic neutrophils labeled
with eFluor670 (red) and were imaged at different time points. Non-internalized
neutrophils were immunostained with anti-CD18 (cyan) at the end of the experiment.
Image is representative of 16 images, taken over 3 independent experiments. Scale bar =
10 µm.
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Figure 10: Rab7 recruitment to apoptotic-neutrophil containing efferosomes.
Rab7-GFP transfected J774.2 cells (green) efferocytosed apoptotic neutrophils labeled
with eFluor670 (red) and were imaged at different time points. Non-internalized
neutrophils were immunostained with anti-CD18 (cyan) at the end of the experiment.
Image is representative of 16 images, taken over 3 independent experiments. Scale bar =
10 µm.
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Figure 11: Quantification of Rab5 and Rab7 on phagosomes and efferosomes.
Rab GTPases mediated maturation process was eluciated by the quantification of Rab5
and Rab7 on phagosomes/efferosomes in each maturation stages. A) The presence of
Rab5/7 on IgG beads containing phagosomes in each time frame was quantified by
dividing numbers of Rab5 or Rab7 positive-structures by the total number of
phagosomes. The presence of Rab5/7 on B) PtdSer beads and C) apoptotic neutrophils
containing efferosomes in each time frame was quantified by dividing numbers of Rab5
or Rab7 positive-structures by the total number of efferosomes. Phagosomes/efferosomes
were counted from two successful independent experiments.
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3.5 Efferosomes Undergo Fusion with Lysosomes
Although the J774.2 murine macrophages cell line revealed that efferosomes recruited
Rab5 and Rab7 in a similar manner to phagosomes, the possibility remains that this is an
artefact of the cell line we are using, thereby primary macrophages were employed to
assess efferosome maturation. At present we cannot transfect primary human
macrophages. Thus, to assess efferosome maturation in primary human macrophages I
immunostained for LAMP-1, a maturation marker that is delivered to phagosomes
through Rab7-mediated fusion of the phagosome with late endosomes and lysosomes73.
M0 macrophages were fed IgG-coated beads (Figure 12A), PtdSer-coated beads (Figure
12B) or eFluor670 labeled apoptotic neutrophils (Figure 12C) for 30 minutes and then
immunostained for LAMP-1. This time point was chosen as our previous results
indicated that Rab7 completely replaced Rab5 by this time on efferosomal and
phagosomal membranes (Figures 7 to 11). LAMP-1 was observed on both the
phagosomal and efferosomal membranes, confirming that efferosomes were undergoing
the classical Rab5-Rab7 maturation process like that utilized by phagosomes.

3.6 Identification of Regulator Proteins on Efferosomes
Although both phagosomes and efferosomes appear to utilize the same maturation
process, the different immunological outcomes of phagocytosis (inflammation,
immunogenic antigen presentation) and efferocytosis (homeostasis, no or tolerogenic
antigen presentation) indicates that the degraded materials in efferosomes is treated
differently than in phagosomes. These differences likely occur in the latest stages of the
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Figure 12: M0 macrophages fuse lysosomes to efferosomes.
Human M0 macrophages phagocytosed A) IgG-coated beads marked by asterisks, B)
PtdSer-coated beads marked by asterisks, or C) apoptotic neutrophils labeled with
eFlour670 (red), for 30 minutes. Cells were then fixed and immunostained for LAMP-1
(green). Images are representative of 14 images, taken over 2 independent experiments.
Scale bars = 10 µm.
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maturation process, after lysosomal fusion. To identify these novel processes an unbiased
mass spectrometry analysis was implemented using M0 macrophages and magnetic
PtdSer-coated beads. A longer time frame of efferocytosis (40 minutes) was used to
ensure that the majority of efferosomes reached the Rab7/LAMP-1 positive (late) stage of
maturation. For comparison, phagosomes containing IgG coated magnetic beads were
isolated at the same time point. To maximize protein recovery I implemented the
reversible cross-link immune-precipitation (ReCLIP) technique which provided better
protein recovery by using two protein cross-linking reagents, Dithiobis (succinimidyl
propionate) and Dithio-bismalemidoehane, to the cells prior to lysis (data not shown)78.
Following lysis, a magnetic column was used to recover the efferosomes and phagosomes,
and SDS-PAGE used to separate the recovered proteins. Coomassie staining revealed
multiple unique protein bands in both the efferosome and phagosome isolates (Figure 13,
arrows). Notably, the total amount of recovered proteins from efferosomes was less than
recovered from phagosomes, likely due to higher levels of phagocytosis than
efferocytosis in unpolarized M0 macrophages.
Bands of interest were excised from the gel and the proteins identified with mass
spectrometry and MASCOT software analysis of the resulting spectra. Proteins with a
MASCOT matching score greater than 40 were considered to be very high-quality hits,
matching scores of 30 – 40 were considered to be high quality hits, and matching score of
20-30 considered medium-quality hits (Tables 4, 5). Proteins with scores below 20 were
not considered to be significant. Several interesting proteins were recovered from
efferosomes with high quality or better scores (score >30, Table 4),
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Figure 13: Multiple unique proteins were recovered from efferosomes and
phagosomes.
PtdSer/PtdCho-coated magnetic beads (efferosome) and IgG-coated magnetic beads
(phagosome) were used as efferocytic targets and recovered from M0 primary human
macrophages at 40 minutes post-internalization. Unique protein bands on each sample are
marked by arrows. Image is representative of 3 independent experiments.

72

73

including regulators of vesicular traffic (Rab1785, RASEF (Rab45)86 and VPS33B87), an
inhibitory phosphatase of MAP Kinase signaling (PP2A)88, the efferocytic receptor
CD3622, a number of actin-regulatory proteins (WIPF3, Rac2 and Talin)49, a negative
regulator of phosphatidylinositide signaling (IMPA2)89, and proteins involved in
ubiquitination (TRIM25, USP15)90, 91. Both MHC I and MHC II92 were identified as
medium-quality hits (score of 20-30, Table 4). Phagosomes recruited a very different
network of proteins. Among the high quality hits (score > 30, Tables 5) were both MHC I
and MHC II92, regulators of Golgi export (Rab6b and PI4-Kinase)93, 94, a number of
protein kinases (MKNK1, MINK1, STK4, PRKAB1)95, 96, 97, 98, the pattern recognition
receptor modulator NLRP3 (NOD3)99, 100, 101, as well as a number regulators of calcium
signaling (INPP5A and STRN3)102, 103. Although numerous hits identified interesting
proteins on both efferosomes and phagosomes, future studies using biochemical or cell
based assays are required to validate these hits and test for the function of these proteins
during efferosome and phagosome maturation.
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Table 4: Summary of all proteins detected by mass spectrometry analysis of isolated
efferosomes.
“Protein Name” and “Protein Symbol” indicate the official gene name listed in the NCBI
database, and “NCBI Accession Number” indicates the specific entry in the NCBI gene
catalogue corresponding to the identified peptides. “Protein Score” indicates the quality
of the match, based on the Mascot software scoring system. “# peptides” indicates the
total number of peptides from each protein identified. “Total residues” indicates the total
number of amino acid residues identified across all peptides. “% Coverage” indicates the
portion of the total protein identified by mass spectrometry. Data is the aggregate of 3
experiments.
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Very	
  High	
  Quality	
  Hits	
  (MASCOT	
  Score	
  >	
  40)	
  
Protein	
  Name	
  

Protein	
  
Symbol

NCBI	
  Accession	
  
Number	
  

Protein	
  
Score	
  

#	
  
peptides	
  

Total	
  
residue	
  

%	
  
Coverage	
  

Size	
  
	
  (kD)	
  

Talin	
  1	
  

TLN1

XP_005251621	
  

67	
  

198	
  

2541	
  

7.79	
  

270	
  

Tripartite	
  motif-‐containing	
  25	
  

TRIM25

EAW94523	
  

52	
  

85	
  

422	
  

20.1	
  

71	
  

MAP4	
  protein	
  

MAP4

AAH48200	
  

51	
  

119	
  

857	
  

13.9	
  

121	
  

Ubiquitin	
  specific	
  peptidase	
  15	
  

USP 15

AAI25124	
  

48	
  

115	
  

952	
  

12.1	
  

112	
  

Leucine	
  rich	
  repeat	
  neuronal	
  1	
  

LRRN1

EAW63901	
  

46	
  

48	
  

84	
  

57.1	
  

81	
  

Galectin	
  3	
  

LGALS3

1KJL_A	
  

46	
  

69	
  

146	
  

47.3	
  

26	
  

Inositol	
  monophosphatase	
  A2b	
  

IMPA2

AAF07824	
  

45	
  

72	
  

261	
  

27.6	
  

31	
  

Ras-‐related	
  protein	
  Rab-‐17	
  

RAB17	
  

XP_006712752	
  

45	
  

69	
  

190	
  

36.3	
  

23	
  

PTPRF	
  interacting	
  protein	
  1	
  

PPFIP1	
  

AAH46159	
  

45	
  

86	
  

272	
  

31.6	
  

114	
  

F-‐box	
  protein	
  Fbx6	
  	
  

FBX6	
  

AAF04470	
  

43	
  

74	
  

338	
  

21.9	
  

34	
  

PTGFRN	
  protein	
  

PTGFRN	
  

AAH98142	
  

40	
  

89	
  

788	
  

11.3	
  

99	
  
	
  

High	
  Quality	
  Hits	
  (MASCOT	
  Score	
  30	
  -‐	
  40)	
  
Protein	
  Name	
  

Protein	
  
Symbol	
  

NCBI	
  Accession	
  
Number	
  

Protein	
  
Score	
  

#	
  
peptides	
  

Total	
  
residue	
  

%	
  
Coverage	
  

Size	
  
	
  (kD)	
  

Vacuolar	
  protein	
  sorting-‐
associated	
  protein	
  33B	
  

VPS33B	
  

XP_003807753	
  

39	
  

95	
  

590	
  

16.1	
  

71	
  

PP2A	
  

NP_060387	
  

37	
  

46	
  

453	
  

10.2	
  

56	
  

WIPF3	
  

XP_005276342	
  

35	
  

48	
  

326	
  

14.7	
  

49	
  

RAC2	
  

P15153	
  

34	
  

19	
  

148	
  

12.8	
  

21	
  

GSK3B	
  

P49841	
  

33	
  

18	
  

18	
  

100	
  

47	
  

MASP1	
  

AAO85801	
  

33	
  

13	
  

84	
  

15.5	
  

79	
  

RASEF	
  (Rab45)	
  

RASEF	
  

Q8IZ41	
  

32	
  

32	
  

44	
  

72.7	
  

83	
  

CD36	
  

SCARB1	
  

AAG60629	
  

30	
  

18	
  

31	
  

58.1	
  

61	
  

Serine/threonine-‐protein	
  
phosphatase	
  2A	
  
WAS/WASL-‐interacting	
  protein	
  
family	
  member	
  3-‐like	
  
Rac2	
  
Glycogen	
  synthase	
  kinase	
  3-‐
beta	
  
Mannin-‐binding	
  lectin	
  serine	
  
protease	
  1	
  

	
  

Medium	
  Quality	
  Hits	
  (MASCOT	
  Score	
  20	
  –	
  30)	
  
Protein	
  Name	
  

Protein	
  
Symbol	
  

NCBI	
  Accession	
  
Number	
  

Protein	
  
Score	
  

#	
  
peptides	
  

Total	
  
residue	
  

%	
  
Coverage	
  

Size	
  
	
  (kD)	
  

Liver	
  alkaline	
  phosphatase	
  

ALPL	
  

MHC	
  class	
  II	
  antigen	
  

HLA-‐
DPB1	
  

AAB24485	
  

29	
  

10	
  

15	
  

66.7	
  

57	
  

AEB91578	
  

29	
  

27	
  

177	
  

15.3	
  

29	
  

Calsyntenin	
  2	
  

CLSTN2	
  

EAW79017	
  

27	
  

49	
  

608	
  

8.06	
  

107	
  

MAP	
  kinase	
  interacting	
  
serine/threonine	
  kinase	
  1	
  

MKNK1	
  

EAX06901	
  

22	
  

12	
  

227	
  

5.29	
  

51	
  

MHC	
  Class	
  I	
  

MR1	
  

AAB22522	
  

22	
  

8	
  

90	
  

8.89	
  

43	
  

76

Table 5: Summary of all proteins detected by mass spectrometry analysis of isolated
phagosomes.
“Protein Name” and “Protein Symbol” indicate the official gene name listed in the NCBI
database, and “NCBI Accession Number” indicates the specific entry in the NCBI gene
catalogue corresponding to the identified peptides. “Protein Score” indicates the quality
of the match, based on the Mascot software scoring system. “# peptides” indicates the
total number of peptides from each protein identified. “Total residues” indicates the total
number of amino acid residues identified across all peptides. “% Coverage” indicates the
portion of the total protein identified by mass spectrometry. Data is the aggregate of 3
experiments.
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Very	
  High	
  Quality	
  Hits	
  (MASCOT	
  Score	
  >	
  40)	
  
Protein	
  Name	
  

Protein	
  
Symbol	
  

NCBI	
  Accession	
  
Number	
  

Protein	
  
Score	
  

#	
  
peptides	
  

Total	
  
residue	
  

%	
  
Coverage	
  

Size	
  
	
  (kD)	
  

CTTNBP2	
  N-‐terminal-‐like	
  protein	
  	
  

CTTNBP2NL	
  

	
  Q9P2B4	
  

61	
  

204	
  

658	
  

31.0	
  

70	
  

MHC	
  class	
  I	
  antigen	
  

MR1	
  

AFZ93953	
  

58	
  

62	
  

181	
  

34.3	
  

39	
  

Insulin-‐like	
  growth	
  factor	
  binding	
  
protein	
  2	
  

IGFBP2	
  

AAA36048	
  

54	
  

126	
  

325	
  

38.8	
  

35	
  

Misshapen-‐like	
  kinase	
  1	
  

MINK1	
  

Q8N4C8	
  

52	
  

91	
  

1298	
  

7.01	
  

150	
  

Acylphosphatase-‐1	
  	
  

ACYP1	
  

P07311	
  

45	
  

37	
  

85	
  

43.5	
  

11	
  

MHC	
  Class	
  II	
  

HLADQB1	
  

AGW82950	
  

44	
  

58	
  

261	
  

22.2	
  

30	
  

Cyclin-‐Y-‐like	
  protein	
  2	
  

CCNYL2	
  

XP_006710109	
  

41	
  

58	
  

174	
  

33.3	
  

41	
  

Lymphoid	
  enhancer-‐binding	
  factor	
  1	
  

LEF1	
  

Q9UJU2	
  

40	
  

89	
  

303	
  

29.4	
  

44	
  

RalA	
  binding	
  protein	
  1	
  

RALBP1	
  

BAD93161	
  

40	
  

82	
  

462	
  

17.7	
  

76	
  

Serine/threonine-‐protein	
  kinase	
  4	
  

STK4	
  

Q13043	
  

40	
  

29	
  

274	
  

10.6	
  

56	
  

Protein	
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Protein	
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peptides	
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residue	
  

%	
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Size	
  
	
  (kD)	
  

Annexin	
  A2	
  

ANXA2	
  

P07355	
  

39	
  

57	
  

287	
  

19.9	
  

39	
  

MAP	
  kinase-‐interacting	
  
serine/threonine-‐protein	
  kinase	
  1	
  	
  

MKNK1	
  

XP_006711064	
  

38	
  

78	
  

418	
  

18.7	
  

51	
  

BCR-‐ABL	
  fusion	
  protein	
  

BCR/ABL	
  

A9UF05	
  

34	
  

46	
  

101	
  

45.5	
  

51	
  

PIK4	
  Kinase	
  

PIK4	
  

P42356	
  

34	
  

56	
  

278	
  

20.1	
  

231	
  

Cytotoxic	
  T-‐lymphocyte	
  protein	
  4	
  

CTLA4	
  

P16410	
  

34	
  

46	
  

174	
  

26.4	
  

25	
  

Type	
  I	
  inositol-‐1,4,5-‐trisphosphate	
  5-‐
phosphatase	
  

INPP5A	
  

Q14642	
  

34	
  

30	
  

31	
  

96.8	
  

48	
  

RAB6B	
  protein	
  

RAB6B	
  

Q9NRW1	
  

34	
  

83	
  

208	
  

39.9	
  

23	
  

Abhydrolase	
  domain	
  containing	
  1	
  

ABHD1	
  

Q96SE0	
  

33	
  

63	
  

186	
  

33.9	
  

45	
  

Lactate	
  dehydrogenase	
  c	
  

LDHC	
  

P07864	
  

33	
  

41	
  

96	
  

42.7	
  

36	
  

Striatin,	
  calmodulin	
  binding	
  protein	
  3	
  

STRN3	
  

Q13033	
  

31	
  

48	
  

445	
  

10.8	
  

87	
  

NOD3	
  protein	
  

NLRC3	
  

EAW85349	
  

30	
  

111	
  

717	
  

15.5	
  

114	
  

5'-‐AMP-‐activated	
  protein	
  kinase	
  
beta-‐1	
  

PRKAB1	
  

Q9Y478	
  

30	
  

15	
  

248	
  

6.05	
  

30	
  

Protein	
  Name	
  

Protein	
  
Symbol	
  

NCBI	
  Accession	
  
Number	
  

Protein	
  
Score	
  

#	
  
peptides	
  

Total	
  
residue	
  

%	
  
Coverage	
  

Size	
  
	
  (kD)	
  

GTPase	
  IMAP	
  family	
  member	
  GIMD1	
  

GIMD1	
  

P0DJR0	
  

27	
  

24	
  

217	
  

11.1	
  

24	
  

Cyclin-‐dependent	
  kinase	
  4	
  

CDK4	
  

P11802	
  

26	
  

20	
  

111	
  

18.0	
  

34	
  

DOCK10	
  protein	
  

DOCK10	
  

Q96BY6	
  

26	
  

58	
  

542	
  

10.7	
  

250	
  

CKLF-‐like	
  MARVEL	
  transmembrane	
  
domain-‐containing	
  protein	
  1	
  

CMTM1	
  

Q8IZ96	
  

23	
  

14	
  

122	
  

11.5	
  

19	
  

Interferon-‐stimulated	
  20	
  kDa	
  
exonuclease-‐like	
  2	
  	
  

ISG20L2	
  

Q9H9L3	
  

20	
  

12	
  

138	
  

8.70	
  

39	
  

High	
  Quality	
  Hits	
  (MASCOT	
  Score	
  30	
  -‐	
  40)	
  

Medium	
  Quality	
  Hits	
  (MASCOT	
  Score	
  20	
  -‐	
  30)	
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Chapter 4 - Discussion
4.1
Rational of the Thesis: Efferosome Maturation
Pathways and the Immune System
Billions of cells undergo programmed cell death every day in our bodies, and those
apoptotic cells must be cleared by efferocytosis. If left uncleared, severe autoimmune and
chronic inflammation can occur following the release of pro-inflammatory and
immunogenic materials through secondary necrosis66. During efferocytosis professional
phagocytes remove apoptotic cells in an anti-inflammatory manner. In contrast,
phagocytosis - a part of the innate immune system - produces pro-inflammatory
responses after engulfing pathogens11. Despite these differences in the immunological
outcome of efferocytosis and phagocytosis, the two processes share a common
degradative pathway mediated by Rab GTPases and fusion events between the forming
efferosome/phagosome and vesicles from the endocytic pathway. This differential
regulation of the outcomes of phagocytosis versus efferocytosis is the key for maintaining
homeostasis under inflammatory versus homeostatic circumstances. Efferocytosis can be
divided to three discrete but sequential stages: 1) recruitment of phagocytes to “find-me”
signals secreted by apoptotic cells, 2) binding and internalization of the apoptotic cell by
engagement of “eat-me” signals by phagocyte receptors, and 3) degradation of the
apoptotic cell via maturation of the efferosome. The maturation process of efferocytosis
has been primarily studied in C. elegans, and much of what is known of this process has
been derived from these studies51. Many proteins involved in efferosome formation and
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maturation, such as CED/Rac and Rab 5/7 are evolutionarily conserved between
nematodes and mammals51, implying that they may serve a common function in
efferocytosis in both groups of organisms. However several observations suggest that
efferocytosis has distinct outcomes between these organisms, suggesting that the
regulation of efferocytosis - or its outcomes - has evolved differently between these two
groups of organisms.
For example, Rab5 activation was inhibited by a lack of Gapex-5, a Rab5 GEF, near the
site of apoptotic cell engagement in a mammalian system but not in C. elegans104.
Moreover, efferocytosis is anti-inflammatory while phagocytosis is pro-inflammatory in a
mammalian system, but both the inflammatory and antigen presentation portions of these
responses do not exist in C. elegans105, 106. In addition, recent studies of mammalian
efferocytosis have identified several novel processes not observed in C. elegans. For
example, Balce et al. revealed that alternately activated M2 mammalian macrophages
showed reduced NADPH oxidase activity in efferosomes, distinct from what is observed
in C. elegans efferosomes and mammalian phagosomes18. Indeed, the C. elegans
efferocytic pathway more closely parallels mammalian phagocytosis pathways than it
does the mammalian efferocytic pathway51. Moreover, studies of dendritic cells suggest
that mammalian efferocytosis may not proceed past the Rab5 stage64, 65, although the
results of this thesis (Figure 7 to 10) would suggest this is a DC-cell specific
phenomenon. Combined, these studies suggest that the mammalian efferocytosis pathway
is regulated differentially from efferocytosis in C. elegans and mammalian phagocytosis,
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thus allowing it to produce the cellular responses key to preventing chronic inflammation
and autoimmunity downstream of apoptotic cell removal.

4.2

Hypothesis and Aims

How these molecular mechanisms controlling mammalian efferosome formation and
maturation are anti-inflammatory/anti-immunogenic are not fully understood. For this
thesis, because efferocytosis and phagocytosis have different inflammatory and
immunogenic outcomes, I hypothesized that phagocytic and efferocytic maturation
pathways are regulated by fusions with different intracellular compartments, and that
these fusion events are regulated by novel mediators recruited either to phagosomes or to
efferosomes. The following research aims were designed to elucidate whether efferosome
maturation was unique, using cell biology and biochemical assays: 1) establish an in vitro
macrophage model of efferocytosis, 2) characterize the acquisition of common
maturation markers (i.e. Rab5, Rab7, LAMP-1) of phagocytosis to efferosomes, and 3)
identify potential novel regulators on efferosomes and phagosomes by mass
spectrometry.

4.3

Development of an In Vitro Efferocytosis Model

All aims of this study required an in vitro efferocytosis model that required both a
consistent and reproducible efferocytic target and a cell line that exhibited strong and
consistent efferocytosis. Generation of apoptotic cells is preferable for studying
efferocytosis as they most closely mimic the in vivo environment, and several methods
have been used by other researchers to induce consistent and high rates of apoptosis for
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these types of assays107, 108. Previous models have included UV exposure, anti-cancer
drugs (e.g. Staurosporine), and physical stresses such as heat-shock or cold-shock
treatment107, 108, 109. Several previous studies adopted staurosporine, an inhibitor of
multiple kinases, to induce apoptosis via activation of caspase 3108, 110. However, in my
hands STS did not generate a sufficient number of apoptotic Jurkat T cells for my
experiments (Figure 1B). To improve on this I utilized another popular model, the heatshocked induce apoptosis of primary human neutrophils75. This induced high rates of
apoptosis in isolated treated neutrophils without measurable necrosis (Figure 2). These
apoptotic neutrophils were readily efferocytosed by J774.2 macrophages, demonstrating
that they are good efferocytic targets (Figure 3).
While the neutrophil-based efferocytosis assay was successful, the availability of
neutrophils was limited. Moreover, these apoptotic neutrophils would not have been
suitable targets for mass spectrometry as it would not be possible to separate proteins
derived from the apoptotic neutrophils from those found on the recovered efferosomes.
As such I developed a bead-based efferocytosis model which provides simple and highly
reproducible apoptotic targets. This method was based on of similar targets developed by
other groups, but was modified to allow for detection of non-internalized versus
internalized beads through the incorporation of biotinylated PtdEtn111, 34, 76. These
efferocytotic targets consisted of silica beads coated with 20% PtdSer and 80% PtdCho
that mimic apoptotic cell membranes, while beads coated with only PtdCho were used to
mimic healthy cells. When required, 0.2% of these lipids were substituted with biotinPtdEtn to allow for detection of non-internalized beads through the addition of
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fluorescently labeled streptavidin. As expected, macrophages only efferocytosed PtdSercoated beads, indicating these were a good model for our PtdSer specific efferocytosis
studies (Figure 4).
In addition to reproducible efferocytic targets, this thesis also required the identification
of macrophage cell lines or primary macrophage subtypes which consistently engage in
efferocytosis. To generate reproducible in vitro model of efferocytosis I utilized J774.2
and M0 primary human macrophages, which consistent with previous studies, were
determined to have high efferocytic capacities (Figures 3, 4)34, 35, 74. While the
RAW264.7 cell line is the most frequently used cell line for phagocytosis studies,
especially studies of phagosome maturation and vesicular trafficking112, 113, I determined
that RAW264.7 and the related ANA-1 cell lines did not internalize PtdSer-coated beads
(data not shown). The differences between the efferocytic capacity of the J774.2 and M0
macrophages versus the ANA-1 and RAW264.7 cell lines is unclear, but I would
hypothesize that each cell line expresses different levels of efferocytic receptors.
Consistent with this hypothesis are studies showing RAW264.7 cells have low expression
of TIM-4114 and CD36115. In contrast, previous studies have also found J774.2 cell have a
high efferocytic capacity, provided by the expression of the receptors for calreticulin and
PtdSer35, 116. Importantly, Figures 4 and 5 demonstrate that macrophages recognized and
internalized only PtdSer-coated beads, but not PtdCho only coated beads, indicating
uptake was specific to the inclusion of the PtdSer “eat-me” signal in these beads. This
specificity may have been provided by expression of the PtdSer specific receptor TIM-4
on J774.2 and M0 macrophages34, 116. Indeed, TIM-4-/- bone marrow-derived
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macrophages (BMDM) showed dramatically reduced internalization of PtdSer-coated
beads in absence of any opsonins, while TIM-4+/+ wild-type primary macrophages
showed extensive uptake of PtdSer-coated beads but not PtdCho beads34. Critically, this
study demonstrates that the recognition of “eat-me” signals in targets containing a mixed
lipid composition is specific to the presence of the eat-me signals present on the beads.

4.4

Macrophage Subtypes and Efferocytosis

Differences in the immunological responses generated by M0, M1 and M2 primary
human macrophages provide insights into their efferocytic capacities. M0 macrophages
resemble the macrophages which patrol healthy tissues, M1 macrophages are
conventional pro-inflammatory cells found at sites of pathogen invasion, and M2
macrophages are alternatively polarized for anti-inflammatory actions such as wound
healing and tissue remodeling12, 13. Figure 5 demonstrates the efferocytic capacities of
each subtype. M0 and M2 macrophages could efferocytose PtdSer-coated beads, whereas
M1 macrophage rarely efferocytosed PtdSer-coated beads. Moreover, the uptake of beads
in M1 cells was not PtdSer-specific, suggesting the observed uptake may have been
chance capture due to the high levels of membrane ruffling and spontaneous membrane
enclosing observed in these cells117. These results followed our predictions, as M2 cells
would require higher efferocytic capacities in order to clear dying cells from wound sites,
M0 macrophages would be expected to engage in efferocytosis are part of their
“housekeeping” activities, while neither of these functions would be required by M1 cells
attempting to restrict an infection. Unexpectedly, the highest phagocytic index (12.5) was
observed in M0 macrophages, not M2 cells, suggesting that in vivo these M0 cells must
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frequently encounter apoptotic cells, suggesting they play a more central role in
homeostasis than previously thought. Indeed, most tissue resident macrophages are
thought to have an M0 phenotype16, suggesting that the bulk of homeostatic efferocytosis
may be performed by these cells rather than by other efferocytic cell types such as
epithelial cells118.

4.5

Role of Rab5 and Rab7 in Efferosome Maturation

Previously, efferosome maturation was characterized in studies of C. elegans, specifically
assaying the removal of the apoptotic cells produced during C. elegans’ development
process51. C. elegans and mammals evolutionarily share many parts of the proteins
regulating phagosome maturation, including the “master regulatory” Rab GTPases and
phosphatidylinositol kinases that regulate much of the maturation process51. Tracking
these protein regulators during C. elegans phagocytosis of apoptotic cell revealed a
process similar to mammalian phagocytosis of pathogens – namely, Rab5 was recruited
to early efferosomes and then supplanted by Rab7 in the later stages51. Moreover, this
study also demonstrated that the small GTPases CED-10 and Rac played a similar role in
in the internalization of apoptotic cells in both mammalian and C. elegans phagocytes.
Upon receptor engagement of apoptotic targets, CED-10 and Rac transmit downstream
signals to induce membrane ruffles and protrusion, driven by actin remodeling, in order
to engulf the apoptotic target. Evolutionary shared processes also regulated the exchange
of Rab5 and Rab7 proteins in C. elegans efferosomes and mammalian phagosomes,
suggesting a shared process regulates both phagosome and efferosome maturation51. The
role of Rab5 and Rab7 in mammalian efferosome maturation remains controversial, as
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other studies have found differences between C. elegans and mammalian efferosome
maturation including findings indicating that the Rab5 to Rab7 transition is delayed or
non-existent in mammalian cells, particularly in dendritic cells where a block in the
Rab5/7 transition appears to preserve antigens until the DC cell matures64, 65.
In this thesis, I determined that Rab5 and Rab7 recruitment in efferosome maturation is
consistent between mammalian macrophages and C. elegans, and that the mammalian
efferosome maturation process closely paralleled phagosome maturation in the same cell
type (Figures 7, 8, 9). Upon uptake of phagocytic and efferocytic targets, the engulfed
particles became Rab5 positive, followed by a rapid exchange of Rab5 for Rab7.
Although not tested in our experiments, this exchange was most likely driven by the
Mon1a and Ccz1 proteins, which then act as a Rab7 GEF complex on efferosomes and
phagosomes52, 59. The presence of Rab7 was associated with fusion to late endosomes and
lysosomes (Figure 7, 9), confirming that Rab7 was active on efferosomes. Late endosome
and lysosome fusion to efferosomes delivers V-ATPase into the efferosomal membrane,
as a result, increasing import of protons and acidifying the efferosome lumen10, 52. These
results ran contrary to our labs preliminary results from the poorly efferocytic RAW264.7
cell line, in which efferocytosis did not proceed past the Rab5 stage. The apparent
conflict between the RAW264.7 cell line and the J774.2 and M0 macrophages maturation
pathways may be due to the inherent M1 polarized phenotype of the RAW264.7 cells119,
or alternatively, due to mutations of maturation-regulating protein acquired during the
immortalization of RAW264.7 cells. A third possibility is that RAW264.7 cells may have
the same Rab5 blockade as that observed in dendritic cells64, 65, suggesting that we may
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be able to use RAW264.7 cells as a model of dendritic cell efferocytosis in future studies.
Indeed, RAW264.7 cells can be differentiated into dendritic-like cells120, suggesting that
RAW264.7 cells may more closely resemble immature dendritic cells than they resemble
macrophages.
While the above results suggest that a shared maturation pathway is used by both
efferosomes and phagosomes, we assessed the Rab7-dependant fusion of late endosomes
and lysosomes to the efferosome using a human system comprised of non-polarized (M0)
primary human macrophages. This was done to confirm our results in endogenous cell
lines free of any defects caused by the mutations that led to immortalization of the cell
lines used in the early experiments. Because we cannot transfect primary macrophages,
we instead assessed the recruitment of the lysosomal protein LAMP-1 to phagosomes
(Figure 10A) and efferosomes (Figure 10B, C). The recruitment of this protein to both
efferosomes and phagosomes indicates that both underwent fusion with lysosomes,
suggesting that full acidification and recruitment of degradative enzymes such as
cathepsins and hydrolases could occur in both compartments52. However lysosomal cargo
delivery to efferosomes was not confirmed. As such future experiments should track
efferosome pH using pH-sensitive fluorescent dextran conjugates121. Should transfection
of these cells become possible, additional assays of Rab7 function such as monitoring the
recruitment of fluorescently tagged Rab7 or one of its effector proteins such as RILP, can
be used to better understand the dynamics of Rab7 activity efferosomes in the human
system10, 52, 60. Although this thesis determined that efferosomes in human macrophages
undergo some degree of lysosomal fusion, it is still unclear whether efferosomes are
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receiving the same complement of degradative proteins as phagosomes. Indeed, it has
been established that other Rab proteins (e.g. Rab34) can induce the selective delivery of
molecules to phagolysosomes, suggesting that other Rab proteins may act downstream of
Rab7 to differentiate efferosome versus phagosomal maturation60.

4.6
Novel Regulators Differentiate Efferosomal from
Phagosomal Maturation
The absence of a major difference between the recruitment of Rab5 and Rab7 to
phagosomes versus efferosomes, and the apparent normal fusion of late endosomes and
lysosomes to both compartments, strongly suggests that there are not major differences in
this portion of the phagosomal versus efferosomal maturation process. However, the
different immunological outcomes of phagocytosis versus efferocytosis suggest that there
must be a difference in the way that phagosomal and efferosomal cargos are trafficked19,
74, 105

. Since the maturation process appears to be the same for both types of

compartments up to the phagolysosome stage, I hypothesized that this difference in cargo
handling must occur within the phagolysosome itself. To test this hypothesis I
implemented a mass spectrometry technique to assess the protein content of purified
phagolysosomes containing apoptotic versus phagocytic targets. This successfully
identified proteins selectively recruited to either types of targets, allowing us to identify
putative functional differences between the efferocytosis and phagocytosis maturation
pathways.
Mass spectrometry revealed three Rab GTPases that were differentially recruited to
efferosomes versus phagosomes (Tables 3, 4). Efferosomes recruited Rab17 and Rab45
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whereas phagosomes recruited Rab6b. Although I was unable to assess the role of these
Rab GTPases in mediating maturation, it seems likely that they play a major role in the
differential trafficking of efferosome- and phagosome-derived cargos. Previous studies
found Rab17 on the basolateral membranes and apical tubules of adherent cells where it
mediates transcytosis85. In addition to its role in transcytosis, Rab17 also interacts with
recycling endosomes and may contribute to filopodia formations122. Rab17 appears to
travel toward cell periphery, suggesting it may be carrying degraded apoptotic material
for “disposal” into the extracellular milieu. Rab45 is not as well characterized and differs
structurally from most other Rabs. Rab45 has two functionally distinct domains: 1)
membrane trafficking regulating coiled-coil proteins in C-termini, and 2) an EF-hand
domain in N-termini with unknown function. Rab45 is present on an uncharacterized
membrane compartment located in the perinuclear area that is reminiscent of the
recycling endosome86. Although Rab45’s subcellular localization is unknown, it is clear
that it is not present on the ER, Golgi or lysosomes, further indicating that the
efferosomes are recruiting trafficking regulators not typically involved in the processing
of phagocytic cargos or immunogenic antigen presentation10, 19, 56. Indeed, the combined
recruitment of Rab17 and Rab45 to efferosomes suggests that efferosomes are interacting
with compartments not typically involved in antigen loading onto MHC molecules, such
as the recycling endosome. Taken together, it suggests that efferosomes engages
recycling endosomes and/or the transcytotic pathway, perhaps to shuttle degraded
materials out of the phagocyte while avoiding the more acidic lysosomal and multi
vesicular body compartment where antigen loading onto MHC II typically occurs56, 85.
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In marked contrast, phagosomes (Table 4) recruited Rab6b along with
phosphatidylinositol kinase 4 (PIK4) and GTPase of the immunity-associated protein 1
(GIMD1), all of which are involved in the trafficking of materials from the Golgi to other
intracellular compartments93, 94, 123. This suggests that the phagosome is in direct
communication with the Golgi, perhaps for the purpose of delivering unloaded MHC II to
the phagosome, for loading with phagosome-derived antigen and subsequent antigen
presentation92. Rab6b GTPases are typically found on the Golgi, ER membranes, and as
well the ER-Golgi intermediate compartments (ERGIC)93, with the presence of Rab6b on
phagosomes suggesting that phagosomes directly fused with Golgi-derived vesicles93.
PI4K generates phosphatidylinositol 4-phosphate, a lipid central to export of vesicles and
proteins from the Golgi and ER to other vesicles and the cell surface94. GIMD1, anchored
by a single C-terminal transmembrane helix, is also found on the membrane of the Golgi.
While GIMD1’s function is unknown, its presence in phagosomes further supports the
conclusion that there is direct trafficking between the Golgi and phagosomes123. Taken
together, the presence of these proteins on phagosomes strongly suggests that late
phagosome maturation occurs through direct interactions with the Golgi, perhaps for the
delivery of antigen presenting MHC II molecules.
Other than distinct vesicular trafficking differences between efferosomes and
phagosomes, different signal transduction proteins were also found to be selectively
recruited to efferosomes and phagosomes. Phagosomes recruited NOD3 and DOCK10
(Table 4), both important proteins in mediating inflammation via NF-kB activation, with
neither protein found on efferosomes124, 125. NOD3 is a member of the Nucleotide-
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binding oligomerization domain-containing proteins family (NOD), of which NOD1 and
NOD2 are the best characterized and known to activate NF-κB and MAP-Kinases (e.g.
ERK1/2)99. While NOD1 and NOD2 are known to binding to bacterial peptidoglycan,
NOD3 is characterized as a critical regulatory component of caspase-1, associated in
interleukin 1β (IL-1β) production in the inflammasome100, 101. Dedicator of cytokinesis 10
(DOCK10) was also recovered on phagosomes. DOCK10 has been reported to induce B
cell activation and IL-4 secretion125. Taken together, the presence of these proteins is
indicative that phagosomes may be engaging or modulating signaling pathways which
induce cytokine production and modulate immune cell activation. This is further
supported by the differential recruitment of other proteins involved in cytokine
production, discussed in detail below.
Of great interest on both phagosomes and efferosomes was the differential recruitment of
MAP-Kinase pathway regulating proteins. Mass spectrometry data identified mitogenactivated protein kinase (MAPK) interacting serine/threonine kinase 1 (MKNK1) on both
efferosomes and phagosomes, although the presence of MKNK1 was much more
probable on phagosomes (Tables 3, 4). MKNK1 acts downstream of MAP-Kinases to
enhance pro-inflammatory cytokine translation95. Although phagosomes and efferosomes
both recruited MKNK1, only phagosomes appeared to recruit additional activating
components of the MAP-Kinase signaling pathway (RalBP1)126, while efferosomes were
highly enriched in the negative regulator of MAP-Kinase singling PP2A, which inhibits
MAP-Kinase signaling by inhibiting Raf and MEK127. The recruitment of these two
distinct sets of MAP-Kinase regulatory proteins suggests different levels of MAP kinase
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activities are derived from efferocytosis and phagocytosis. MAP kinases are critical
downstream signaling transducers of pro-inflammatory receptors, often leading to the
production of several pro-inflammatory cytokines by NF-κB activation128. Upon
activation of Raf, the downstream signal protein of Rac, MAP kinase kinases (MAP2K)
are activated to phosphorylate MAP kinases such as p38 MAPK, Erk and Jnk88. p38
MAPK and Erk subsequently phosphate MKNK1, which enhances cytokine production
by phosphorylating EIF4E, an elongation factor that promotes cytokine translation129.
The presence of two positive regulators of MAP-kinase signaling on phagosomes, along
with the low abundance of PP2A, suggests that the phagosomes likely induced signaling
through MAP-Kinase cascades, accounting for the pro-inflammatory, NF-κB-dependent
production of cytokines observed downstream of Fcγ-mediated phagocytosis95.
Efferosomes recruited an abundant quantity of PP2A, a serine/threonine phosphatase that
antagonizes MAP-Kinase signaling through dephosphorylation of multiple members of
the MAP-Kinase signalling cascade127, suggesting that the presence of this phosphatase
may be why efferocytosis does not induce NF-κB-dependent pro-inflammatory cytokines.
Another protein of interest is galectin-3, which was found on efferosomes (Table 3), as
this protein is associated with pro-healing and tissue remodeling activities such as
fibrogenesis and wound repair13. In addition, recent studies have shown that galectin-3
also enhances anti-inflammatory responses and promotes the resolution of
inflammation130. Indeed, galectin-3 has been shown to be important in wound-healing in
various tissues, with galectin-3 deficiency caused impaired wound healing and promoted
chronic inflammation (e.g. inflammatory bowel disease)131. Galectin-3 is actively
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involved in macrophage biology, especially related to polarization into wound healing
phenotypes, and its anti-inflammatory action directly leads to decreased antigen
presentation to Th1 cells, although the mechanism of this reduced antigen presentation
remains unkonwn130, 132, 133. Efferocytosis of apoptotic hepatocytes by hepatic stellate
cells increased galectin-3 production and secretion, along with TGF-β secretion, further
linking galectin-3 to anti-inflammatory responses134, 135. Other studies also revealed that
galectin-3 induced fibrogenesis by myofibroblast proliferation activity in liver tissues,
potentially by inducing secretion of fibroblast growth factor 2 (FGF2) by macrophages; a
process known to lead to fibroblasts differentiation into myofibroblasts that form scar
tissues in wound sites in other tissues13, 136, 137. Taken together, these studies suggest that
the galectin-3 found on efferosomes may play a role in the anti-inflammatory, pro-wound
healing outcome of efferocytosis.

4.7

Summary and Future Aims

In summary, I have assessed the early and late steps of efferosomes maturation in the
mammalian system and compared these to the equivalent stages in phagosome
maturation. I determined that the early maturation stages appear to be identical between
efferocytosis and phagocytosis, with Rab5 recruited early after internalization and then
replaced with Rab7 and fusion with late endosomes/lysosomes at later time points. This
indicates that efferosomes should undergo acidification with the subsequent activation in
proteases and other degradative enzymes to process apoptotic cells51, although I was not
able to test this directly in this thesis. Mass spectrometry analysis of efferosomes and
phagosomes at the phagolysosome stage of maturation identified several interesting
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differences between phagosomes and lysosomes, potentially identifying the mechanism
by which efferocytic cargos induce the opposite immune response as do phagocytic
cargos. For example, different vesicular trafficking mediated by Rab17 and Rab45 may
keep efferosome-derived antigens from the antigen-loading compartment in macrophages
by directing these antigens to recycling endosomes. In contrast, phagosomes had
abundant MHC II and directly interacted with the Golgi trafficking regulators Rab6b,
PIK4 and GIMD1, indicating the phagosome was receiving MHC II directly from the
Golgi network, perhaps for efficient loading of pathogen-derived antigens onto MHC II.
Lastly, MAP kinase regulators accumulated on efferosomes and phagosomes in a pattern
suggesting that MAP Kinase activity and NF-κB activation would occur on phagosomes
but be impaired on efferosomes. These findings will lead to future studies which will
seek to validate the mass spectrometry observations, and to characterize the roles of these
proteins in mediating the differential immune responses following efferocytosis and
phagocytosis.
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